<!DOCTYPE html>
<html lang="en">
  <head prefix="og: http://ogp.me/ns# fb: http://ogp.me/ns/fb# 2490221586: http://ogp.me/ns/fb/2490221586#">
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1, user-scalable=no" />
    <meta name="include_mode" content="async">

    <!-- SL:start:notranslate -->
    <title>HTA Uncovered february 2014</title>
    <meta name="description" content="HTA Uncovered Is s u e N o. 4 – Fe br ua r y 2 0 14 Impact of accountable-care organizations on biopharmaceutical reimbursement and access Accountable care org…">
    <!-- SL:end:notranslate -->

    <meta name="robots" content="index">
    <meta id='globalTrackingUrl' content="https://www.linkedin.com/li/track">
      
<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"agent":"","transactionName":"cV9ZRUZWXQ1XEU1FDVtUUkJcVkZORAoHQQ==","errorBeacon":"bam.nr-data.net","queueTime":0,"applicationID":"22199103","licenseKey":"64463c96e4","beacon":"bam.nr-data.net","applicationTime":876}</script>
<script type="text/javascript">(window.NREUM||(NREUM={})).loader_config={xpid:"XQ4PQlRRCQoJVVFR"};window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{c.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(15),c={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(c.console=!0,o.indexOf("dev")!==-1&&(c.dev=!0),o.indexOf("nr_dev")!==-1&&(c.nrDev=!0))}catch(s){}c.nrDev&&i.on("internal-error",function(t){r(t.stack)}),c.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),c.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(c,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,o){try{d?d-=1:i("err",[o||new UncaughtException(t,e,n)])}catch(c){try{i("ierr",[c,(new Date).getTime(),!0])}catch(s){}}return"function"==typeof f&&f.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t){i("err",[t,(new Date).getTime()])}var i=t("handle"),a=t(16),c=t("ee"),s=t("loader"),f=window.onerror,u=!1,d=0;s.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(l){"stack"in l&&(t(8),t(7),"addEventListener"in window&&t(5),s.xhrWrappable&&t(9),u=!0)}c.on("fn-start",function(t,e,n){u&&(d+=1)}),c.on("fn-err",function(t,e,n){u&&(this.thrown=!0,o(n))}),c.on("fn-end",function(){u&&!this.thrown&&d>0&&(d-=1)}),c.on("internal-error",function(t){i("ierr",[t,(new Date).getTime(),!0])})},{}],3:[function(t,e,n){t("loader").features.ins=!0},{}],4:[function(t,e,n){function r(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var o=t("ee"),i=t("handle"),a=t(8),c=t(7),s="learResourceTimings",f="addEventListener",u="resourcetimingbufferfull",d="bstResource",l="resource",p="-start",h="-end",m="fn"+p,w="fn"+h,v="bstTimer",y="pushState";t("loader").features.stn=!0,t(6);var g=NREUM.o.EV;o.on(m,function(t,e){var n=t[0];n instanceof g&&(this.bstStart=Date.now())}),o.on(w,function(t,e){var n=t[0];n instanceof g&&i("bst",[n,e,this.bstStart,Date.now()])}),a.on(m,function(t,e,n){this.bstStart=Date.now(),this.bstType=n}),a.on(w,function(t,e){i(v,[e,this.bstStart,Date.now(),this.bstType])}),c.on(m,function(){this.bstStart=Date.now()}),c.on(w,function(t,e){i(v,[e,this.bstStart,Date.now(),"requestAnimationFrame"])}),o.on(y+p,function(t){this.time=Date.now(),this.startPath=location.pathname+location.hash}),o.on(y+h,function(t){i("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),f in window.performance&&(window.performance["c"+s]?window.performance[f](u,function(t){i(d,[window.performance.getEntriesByType(l)]),window.performance["c"+s]()},!1):window.performance[f]("webkit"+u,function(t){i(d,[window.performance.getEntriesByType(l)]),window.performance["webkitC"+s]()},!1)),document[f]("scroll",r,!1),document[f]("keypress",r,!1),document[f]("click",r,!1)}},{}],5:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){c.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),c=t(17)(a,!0),s=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1],r=s(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?c(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],6:[function(t,e,n){var r=t("ee").get("history"),o=t(17)(r);e.exports=r,o.inPlace(window.history,["pushState","replaceState"],"-")},{}],7:[function(t,e,n){var r=t("ee").get("raf"),o=t(17)(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],8:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration="number"==typeof t[1]?t[1]:0,t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t(17)(i),c="setTimeout",s="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[c,"setImmediate"],c+d),a.inPlace(window,[s],s+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(s+u,r),i.on(c+u,o)},{}],9:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",c)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,w,"fn-",c)}function i(t){v.push(t),h&&(g=-g,b.data=g)}function a(){for(var t=0;t<v.length;t++)r([],v[t]);v.length&&(v=[])}function c(t,e){return e}function s(t,e){for(var n in t)e[n]=t[n];return e}t(5);var f=t("ee"),u=f.get("xhr"),d=t(17)(u),l=NREUM.o,p=l.XHR,h=l.MO,m="readystatechange",w=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],v=[];e.exports=u;var y=window.XMLHttpRequest=function(t){var e=new p(t);try{u.emit("new-xhr",[e],e),e.addEventListener(m,o,!1)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(s(p,y),y.prototype=p.prototype,d.inPlace(y.prototype,["open","send"],"-xhr-",c),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),h){var g=1,b=document.createTextNode(g);new h(a).observe(b,{characterData:!0})}else f.on("fn-end",function(t){t[0]&&t[0].type===m||a()})},{}],10:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<d;r++)t.removeEventListener(u[r],this.listener,!1);if(!e.aborted){if(n.duration=(new Date).getTime()-this.startTime,4===t.readyState){e.status=t.status;var i=o(t,this.lastSize);if(i&&(n.rxSize=i),this.sameOrigin){var a=t.getResponseHeader("X-NewRelic-App-Data");a&&(e.cat=a.split(", ").pop())}}else e.status=0;n.cbTime=this.cbTime,f.emit("xhr-done",[t],t),c("xhr",[e,n,this.startTime])}}}function o(t,e){var n=t.responseType;if("json"===n&&null!==e)return e;var r="arraybuffer"===n||"blob"===n||"json"===n?t.response:t.responseText;return h(r)}function i(t,e){var n=s(e),r=t.params;r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.sameOrigin=n.sameOrigin}var a=t("loader");if(a.xhrWrappable){var c=t("handle"),s=t(11),f=t("ee"),u=["load","error","abort","timeout"],d=u.length,l=t("id"),p=t(14),h=t(13),m=window.XMLHttpRequest;a.features.xhr=!0,t(9),f.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,p&&(p>34||p<10)||window.opera||t.addEventListener("progress",function(t){e.lastSize=t.loaded},!1)}),f.on("open-xhr-start",function(t){this.params={method:t[0]},i(this,t[1]),this.metrics={}}),f.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid)}),f.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=h(r);i&&(n.txSize=i)}this.startTime=(new Date).getTime(),this.listener=function(t){try{"abort"===t.type&&(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{f.emit("internal-error",[n])}catch(r){}}};for(var a=0;a<d;a++)e.addEventListener(u[a],this.listener,!1)}),f.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),f.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),f.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),f.on("addEventListener-end",function(t,e){e instanceof m&&"load"===t[0]&&f.emit("xhr-load-added",[t[1],t[2]],e)}),f.on("removeEventListener-end",function(t,e){e instanceof m&&"load"===t[0]&&f.emit("xhr-load-removed",[t[1],t[2]],e)}),f.on("fn-start",function(t,e,n){e instanceof m&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=(new Date).getTime()))}),f.on("fn-end",function(t,e){this.xhrCbStart&&f.emit("xhr-cb-time",[(new Date).getTime()-this.xhrCbStart,this.onload,e],e)})}},{}],11:[function(t,e,n){e.exports=function(t){var e=document.createElement("a"),n=window.location,r={};e.href=t,r.port=e.port;var o=e.href.split("://");!r.port&&o[1]&&(r.port=o[1].split("/")[0].split("@").pop().split(":")[1]),r.port&&"0"!==r.port||(r.port="https"===o[0]?"443":"80"),r.hostname=e.hostname||n.hostname,r.pathname=e.pathname,r.protocol=o[0],"/"!==r.pathname.charAt(0)&&(r.pathname="/"+r.pathname);var i=!e.protocol||":"===e.protocol||e.protocol===n.protocol,a=e.hostname===document.domain&&e.port===n.port;return r.sameOrigin=i&&(!e.hostname||a),r}},{}],12:[function(t,e,n){function r(){}function o(t,e,n){return function(){return i(t,[(new Date).getTime()].concat(c(arguments)),e?null:this,n),e?void 0:this}}var i=t("handle"),a=t(15),c=t(16),s=t("ee").get("tracer"),f=NREUM;"undefined"==typeof window.newrelic&&(newrelic=f);var u=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit"],d="api-",l=d+"ixn-";a(u,function(t,e){f[e]=o(d+e,!0,"api")}),f.addPageAction=o(d+"addPageAction",!0),f.setCurrentRouteName=o(d+"routeName",!0),e.exports=newrelic,f.interaction=function(){return(new r).get()};var p=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(l+"tracer",[Date.now(),t,n],r),function(){if(s.emit((o?"":"no-")+"fn-start",[Date.now(),r,o],n),o)try{return e.apply(this,arguments)}finally{s.emit("fn-end",[Date.now()],n)}}}};a("setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){p[e]=o(l+e)}),newrelic.noticeError=function(t){"string"==typeof t&&(t=new Error(t)),i("err",[t,(new Date).getTime()])}},{}],13:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],14:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],15:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],16:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],17:[function(t,e,n){function r(t){return!(t&&t instanceof Function&&t.apply&&!t[a])}var o=t("ee"),i=t(16),a="nr@original",c=Object.prototype.hasOwnProperty,s=!1;e.exports=function(t,e){function n(t,e,n,o){function nrWrapper(){var r,a,c,s;try{a=this,r=i(arguments),c="function"==typeof n?n(r,a):n||{}}catch(f){l([f,"",[r,a,o],c])}u(e+"start",[r,a,o],c);try{return s=t.apply(a,r)}catch(d){throw u(e+"err",[r,a,d],c),d}finally{u(e+"end",[r,a,s],c)}}return r(t)?t:(e||(e=""),nrWrapper[a]=t,d(t,nrWrapper),nrWrapper)}function f(t,e,o,i){o||(o="");var a,c,s,f="-"===o.charAt(0);for(s=0;s<e.length;s++)c=e[s],a=t[c],r(a)||(t[c]=n(a,f?c+o:o,i,c))}function u(n,r,o){if(!s||e){var i=s;s=!0;try{t.emit(n,r,o)}catch(a){l([a,n,r,o])}s=i}}function d(t,e){if(Object.defineProperty&&Object.keys)try{var n=Object.keys(t);return n.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(r){l([r])}for(var o in t)c.call(t,o)&&(e[o]=t[o]);return e}function l(e){try{t.emit("internal-error",e)}catch(n){}}return t||(t=o),n.inPlace=f,n.flag=a,n}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?s(t,c,i):i()}function n(n,r,o){if(!l.aborted){t&&t(n,r,o);for(var i=e(o),a=h(n),c=a.length,s=0;s<c;s++)a[s].apply(i,r);var f=u[y[n]];return f&&f.push([g,n,r,i]),i}}function p(t,e){v[t]=h(t).concat(e)}function h(t){return v[t]||[]}function m(t){return d[t]=d[t]||o(n)}function w(t,e){f(t,function(t,n){e=e||"feature",y[n]=e,e in u||(u[e]=[])})}var v={},y={},g={on:p,emit:n,get:m,listeners:h,context:e,buffer:w,abort:a,aborted:!1};return g}function i(){return new r}function a(){(u.api||u.feature)&&(l.aborted=!0,u=l.backlog={})}var c="nr@context",s=t("gos"),f=t(15),u={},d={},l=e.exports=o();l.backlog=u},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!b++){var t=g.info=NREUM.info,e=d.getElementsByTagName("script")[0];if(setTimeout(f.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return f.abort();s(v,function(e,n){t[e]||(t[e]=n)}),c("mark",["onload",a()],null,"api");var n=d.createElement("script");n.src="https://"+t.agent,e.parentNode.insertBefore(n,e)}}function o(){"complete"===d.readyState&&i()}function i(){c("mark",["domContent",a()],null,"api")}function a(){return(new Date).getTime()}var c=t("handle"),s=t(15),f=t("ee"),u=window,d=u.document,l="addEventListener",p="attachEvent",h=u.XMLHttpRequest,m=h&&h.prototype;NREUM.o={ST:setTimeout,CT:clearTimeout,XHR:h,REQ:u.Request,EV:u.Event,PR:u.Promise,MO:u.MutationObserver},t(12);var w=""+location,v={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-998.min.js"},y=h&&m&&m[l]&&!/CriOS/.test(navigator.userAgent),g=e.exports={offset:a(),origin:w,features:{},xhrWrappable:y};d[l]?(d[l]("DOMContentLoaded",i,!1),u[l]("load",r,!1)):(d[p]("onreadystatechange",o),u[p]("onload",r)),c("mark",["firstbyte",a()],null,"api");var b=0},{}]},{},["loader",2,10,4,3]);</script>
  <!-- SL:start:notranslate -->
  <meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
  <meta http-equiv="x-dns-prefetch-control" content="on">
  <meta name="thumbnail" content="http://cdn.slidesharecdn.com/ss_thumbnails/htauncoveredfebruary2014-140228051012-phpapp02-thumbnail.jpg?cb=1393564255" />
  <!-- SL:end:notranslate -->
  <meta content="{&quot;selected&quot;:&quot;Selected&quot;,&quot;clipping.toast.change_clipboard&quot;:&quot;Change clipboard&quot;,&quot;ajax_signup.login.contest&quot;:&quot;Login to SlideShare to vote\u2026&quot;,&quot;slideview.comments_loggedin.delete_comment.title&quot;:&quot;Are you sure you want to delete this comment?&quot;,&quot;slideview.comments_loggedin.organization&quot;:&quot;at {:organization}&quot;,&quot;action-bar.unlike.text&quot;:&quot;Unlike&quot;,&quot;lynda.domain&quot;:&quot;lynda&quot;,&quot;ajax_signup.login.user&quot;:&quot;Login to SlideShare to register the username\u2026&quot;,&quot;ajax_signup.signup.download&quot;:&quot;Signup for SlideShare to download\u2026&quot;,&quot;ajax_signup.signup.favorite&quot;:&quot;Signup for SlideShare to like\u2026&quot;,&quot;ajax_signup.signup.contest&quot;:&quot;Signup for SlideShare to vote\u2026&quot;,&quot;ajax_signup.signup.create&quot;:&quot;Signup for SlideShare to start creating\u2026&quot;,&quot;ajax_signup.connect&quot;:&quot;connect&quot;,&quot;slideview.comments_loggedin.spam_comment.title&quot;:&quot;Are you sure you want to mark this comment as spam?&quot;,&quot;slideview.comments_loggedin.block_user.failure&quot;:&quot;Oops! Something went wrong. Please try again after sometime.&quot;,&quot;ajax_signup.login.addcontact&quot;:&quot;Login to SlideShare to follow\u2026&quot;,&quot;ajax_signup.login.zipcast&quot;:&quot;Login to SlideShare to schedule a meeting\u2026&quot;,&quot;ajax_signup.signup.addcontact&quot;:&quot;Signup for SlideShare to follow\u2026&quot;,&quot;ajax_signup.signup.follow&quot;:&quot;Signup for SlideShare to follow this user\u2026&quot;,&quot;ajax_signup.signup.zipcast&quot;:&quot;Signup for SlideShare to schedule a meeting\u2026&quot;,&quot;ajax_signup.signup.clip&quot;:&quot;Signup for SlideShare. Don\u2019t lose your clips!&quot;,&quot;li_connect.slideshare_added&quot;:&quot;Your SlideShare was successfully added to your LinkedIn profile.&quot;,&quot;ajax_signup.login.download&quot;:&quot;Login to SlideShare to download\u2026&quot;,&quot;ajax_signup.login.rsvp&quot;:&quot;Login to SlideShare to join this meeting\u2026&quot;,&quot;ajax_signup.signup_for_ss&quot;:&quot;Signup for SlideShare&quot;,&quot;ajax_signup.signup.upload&quot;:&quot;Signup for SlideShare to start uploading\u2026&quot;,&quot;ajax_signup.signup.user&quot;:&quot;Signup for SlideShare to register the username\u2026&quot;,&quot;right_rail.recommended&quot;:&quot;Recommended&quot;,&quot;select&quot;:&quot;Select&quot;,&quot;clipping.select_clipboard_modal.select_new_clipboard&quot;:&quot;Select a new clipboard&quot;,&quot;clipping.toast.share_clip&quot;:&quot;Share clip&quot;,&quot;ajax_signup.login.favorite&quot;:&quot;Login to SlideShare to like\u2026&quot;,&quot;ajax_signup.login.business&quot;:&quot;Login to SlideShare to continue\u2026&quot;,&quot;clipping.select_clipboard_modal.select_another_clipboard&quot;:&quot;Select another clipboard&quot;,&quot;li_connect.login.no_match&quot;:&quot;Login does not match, please try again.&quot;,&quot;ajax_signup.login.upload&quot;:&quot;Login to SlideShare to start uploading\u2026&quot;,&quot;ajax_signup.signup.rsvp&quot;:&quot;Signup for SlideShare to join this meeting\u2026&quot;,&quot;slideview.comments_loggedin.commenting.failure&quot;:&quot;Hey something went wrong :-(\nCould you try again?&quot;,&quot;slideshow.foundation_slideview.likes_count&quot;:&quot;{:count,number} {:count,choice,singular#Like|plural#Likes}&quot;,&quot;lynda.tld&quot;:&quot;.com&quot;,&quot;views.other&quot;:&quot;views&quot;,&quot;ajax_signup.login.comments&quot;:&quot;Login to SlideShare to post a comment\u2026&quot;,&quot;slideview.comments_loggedin.block_user.success&quot;:&quot;The user is blocked!&quot;,&quot;slideview.comments_loggedin.timestamp&quot;:&quot;less than a second ago&quot;,&quot;slideshow.foundation_slideview.like&quot;:&quot;Like&quot;,&quot;ajax_signup.signup.AddToCommunity&quot;:&quot;Signup for SlideShare to add this document to a group/event\u2026&quot;,&quot;ajax_signup.signup.business&quot;:&quot;Signup for SlideShare to continue\u2026&quot;,&quot;slideview.comments_loggedin.block_user.title&quot;:&quot;Are you sure you want to block this user?&quot;,&quot;action-bar.like.why_not_share&quot;:&quot;Like this? Why not share?&quot;,&quot;ajax_signup.login.follow&quot;:&quot;Login to SlideShare to follow this user\u2026&quot;,&quot;ajax_signup.login.create&quot;:&quot;Login to SlideShare to start creating\u2026&quot;,&quot;ajax_signup.signup.comments&quot;:&quot;Signup for SlideShare to post a comment\u2026&quot;,&quot;clipping.filmstrip.message&quot;:&quot;Top clipped slide&quot;,&quot;lynda.premium_video&quot;:&quot;PREMIUM VIDEO&quot;,&quot;share&quot;:&quot;Share&quot;,&quot;ajax_signup.login.AddToCommunity&quot;:&quot;Login to SlideShare to add this document to a group/event\u2026&quot;,&quot;ajax_signup.login.clip&quot;:&quot;Login to SlideShare. Don\u2019t lose your clips!&quot;,&quot;ajax_signup.login_to_ss&quot;:&quot;Login to SlideShare&quot;}" name="ss-i18n-translations" />
  <meta content="{&quot;ssplayer.event_manager.playershare.share_slideshare&quot;:&quot;Share SlideShare&quot;,&quot;lead_form.phone.format.example&quot;:&quot;Ex: +00 0000000000&quot;,&quot;profile.edit_marketing_settings.saved&quot;:&quot;Saved&quot;,&quot;lead_form.phone.international_format_message&quot;:&quot;Please use international phone number format:&quot;}" name="ss-i18n-translations" />

    <link rel="shortcut icon" href="http://public.slidesharecdn.com/b/favicon.ico?d8e2a4ed15">
    <link rel="alternate" type="application/rss+xml" title="RSS" href="http://www.slideshare.net/rss/latest" />
    <link rel="search" type="application/opensearchdescription+xml" href="/opensearch.xml" title="SlideShare Search">

    <link href="http://public.slidesharecdn.com/b/ss_foundation/stylesheets/app_critical.css?d003f4b82b" media="screen" rel="stylesheet" type="text/css" />
    <!--[if IE 9]><link href="http://public.slidesharecdn.com/b/ss_foundation/stylesheets/ie9_nav_bar_fix.css?8fb8af5274" media="screen" rel="stylesheet" type="text/css" /><![endif]-->
    <link rel="alternate" hreflang="en" href="http://www.slideshare.net/harshadoddihal/hta-uncovered-february-2014-31757069"/>
<link rel="alternate" hreflang="es" href="http://es.slideshare.net/harshadoddihal/hta-uncovered-february-2014-31757069"/>
<link rel="alternate" hreflang="fr" href="http://fr.slideshare.net/harshadoddihal/hta-uncovered-february-2014-31757069"/>
<link rel="alternate" hreflang="de" href="http://de.slideshare.net/harshadoddihal/hta-uncovered-february-2014-31757069"/>
<link rel="alternate" hreflang="pt" href="http://pt.slideshare.net/harshadoddihal/hta-uncovered-february-2014-31757069"/>
<link rel="alternate" hreflang="x-default" href= "http://www.slideshare.net/harshadoddihal/hta-uncovered-february-2014-31757069"/>


      <meta content="index" name="robots" />

  <link href="http://public.slidesharecdn.com/b/ss_foundation/stylesheets/slideview_critical.css?d64cac2a3c" media="screen" rel="stylesheet" type="text/css" />

    

<link href="http://public.slidesharecdn.com/b/stylesheets/ssplayer/combined_document.css?6a494d3876" media="screen" rel="stylesheet" type="text/css" />



    <link rel="dns-prefetch" href="//www.slideshare.net">
    <link rel="dns-prefetch" href="//public.slidesharecdn.com">
    <link rel="dns-prefetch" href="//image.slidesharecdn.com">
    <link rel="dns-prefetch" href="//cdn.slidesharecdn.com">
    <link rel="dns-prefetch" href="//www.linkedin.com">

    <script type='text/javascript'>
      // Inlining Modernizr
      window.Modernizr=function(a,b,c){function d(a){t.cssText=a}function e(a,b){return d(x.join(a+";")+(b||""))}function f(a,b){return typeof a===b}function g(a,b){return!!~(""+a).indexOf(b)}function h(a,b){for(var d in a){var e=a[d];if(!g(e,"-")&&t[e]!==c)return"pfx"==b?e:!0}return!1}function i(a,b,d){for(var e in a){var g=b[a[e]];if(g!==c)return d===!1?a[e]:f(g,"function")?g.bind(d||b):g}return!1}function j(a,b,c){var d=a.charAt(0).toUpperCase()+a.slice(1),e=(a+" "+z.join(d+" ")+d).split(" ");return f(b,"string")||f(b,"undefined")?h(e,b):(e=(a+" "+A.join(d+" ")+d).split(" "),i(e,b,c))}function k(){o.input=function(c){for(var d=0,e=c.length;e>d;d++)E[c[d]]=!!(c[d]in u);return E.list&&(E.list=!(!b.createElement("datalist")||!a.HTMLDataListElement)),E}("autocomplete autofocus list placeholder max min multiple pattern required step".split(" ")),o.inputtypes=function(a){for(var d,e,f,g=0,h=a.length;h>g;g++)u.setAttribute("type",e=a[g]),d="text"!==u.type,d&&(u.value=v,u.style.cssText="position:absolute;visibility:hidden;",/^range$/.test(e)&&u.style.WebkitAppearance!==c?(q.appendChild(u),f=b.defaultView,d=f.getComputedStyle&&"textfield"!==f.getComputedStyle(u,null).WebkitAppearance&&0!==u.offsetHeight,q.removeChild(u)):/^(search|tel)$/.test(e)||(d=/^(url|email)$/.test(e)?u.checkValidity&&u.checkValidity()===!1:u.value!=v)),D[a[g]]=!!d;return D}("search tel url email datetime date month week time datetime-local number range color".split(" "))}var l,m,n="2.8.2",o={},p=!0,q=b.documentElement,r="modernizr",s=b.createElement(r),t=s.style,u=b.createElement("input"),v=":)",w={}.toString,x=" -webkit- -moz- -o- -ms- ".split(" "),y="Webkit Moz O ms",z=y.split(" "),A=y.toLowerCase().split(" "),B={svg:"http://www.w3.org/2000/svg"},C={},D={},E={},F=[],G=F.slice,H=function(a,c,d,e){var f,g,h,i,j=b.createElement("div"),k=b.body,l=k||b.createElement("body");if(parseInt(d,10))for(;d--;)h=b.createElement("div"),h.id=e?e[d]:r+(d+1),j.appendChild(h);return f=["&#173;",'<style id="s',r,'">',a,"</style>"].join(""),j.id=r,(k?j:l).innerHTML+=f,l.appendChild(j),k||(l.style.background="",l.style.overflow="hidden",i=q.style.overflow,q.style.overflow="hidden",q.appendChild(l)),g=c(j,a),k?j.parentNode.removeChild(j):(l.parentNode.removeChild(l),q.style.overflow=i),!!g},I=function(b){var c=a.matchMedia||a.msMatchMedia;if(c)return c(b)&&c(b).matches||!1;var d;return H("@media "+b+" { #"+r+" { position: absolute; } }",function(b){d="absolute"==(a.getComputedStyle?getComputedStyle(b,null):b.currentStyle).position}),d},J=function(){function a(a,e){e=e||b.createElement(d[a]||"div"),a="on"+a;var g=a in e;return g||(e.setAttribute||(e=b.createElement("div")),e.setAttribute&&e.removeAttribute&&(e.setAttribute(a,""),g=f(e[a],"function"),f(e[a],"undefined")||(e[a]=c),e.removeAttribute(a))),e=null,g}var d={select:"input",change:"input",submit:"form",reset:"form",error:"img",load:"img",abort:"img"};return a}(),K={}.hasOwnProperty;m=f(K,"undefined")||f(K.call,"undefined")?function(a,b){return b in a&&f(a.constructor.prototype[b],"undefined")}:function(a,b){return K.call(a,b)},Function.prototype.bind||(Function.prototype.bind=function(a){var b=this;if("function"!=typeof b)throw new TypeError;var c=G.call(arguments,1),d=function(){if(this instanceof d){var e=function(){};e.prototype=b.prototype;var f=new e,g=b.apply(f,c.concat(G.call(arguments)));return Object(g)===g?g:f}return b.apply(a,c.concat(G.call(arguments)))};return d}),C.flexbox=function(){return j("flexWrap")},C.flexboxlegacy=function(){return j("boxDirection")},C.canvas=function(){var a=b.createElement("canvas");return!(!a.getContext||!a.getContext("2d"))},C.canvastext=function(){return!(!o.canvas||!f(b.createElement("canvas").getContext("2d").fillText,"function"))},C.webgl=function(){return!!a.WebGLRenderingContext},C.touch=function(){var c;return"ontouchstart"in a||a.DocumentTouch&&b instanceof DocumentTouch?c=!0:H(["@media (",x.join("touch-enabled),("),r,")","{#modernizr{top:9px;position:absolute}}"].join(""),function(a){c=9===a.offsetTop}),c},C.geolocation=function(){return"geolocation"in navigator},C.postmessage=function(){return!!a.postMessage},C.websqldatabase=function(){return!!a.openDatabase},C.indexedDB=function(){return!!j("indexedDB",a)},C.hashchange=function(){return J("hashchange",a)&&(b.documentMode===c||b.documentMode>7)},C.history=function(){return!(!a.history||!history.pushState)},C.draganddrop=function(){var a=b.createElement("div");return"draggable"in a||"ondragstart"in a&&"ondrop"in a},C.websockets=function(){return"WebSocket"in a||"MozWebSocket"in a},C.rgba=function(){return d("background-color:rgba(150,255,150,.5)"),g(t.backgroundColor,"rgba")},C.hsla=function(){return d("background-color:hsla(120,40%,100%,.5)"),g(t.backgroundColor,"rgba")||g(t.backgroundColor,"hsla")},C.multiplebgs=function(){return d("background:url(https://),url(https://),red url(https://)"),/(url\s*\(.*?){3}/.test(t.background)},C.backgroundsize=function(){return j("backgroundSize")},C.borderimage=function(){return j("borderImage")},C.borderradius=function(){return j("borderRadius")},C.boxshadow=function(){return j("boxShadow")},C.textshadow=function(){return""===b.createElement("div").style.textShadow},C.opacity=function(){return e("opacity:.55"),/^0.55$/.test(t.opacity)},C.cssanimations=function(){return j("animationName")},C.csscolumns=function(){return j("columnCount")},C.cssgradients=function(){var a="background-image:",b="gradient(linear,left top,right bottom,from(#9f9),to(white));",c="linear-gradient(left top,#9f9, white);";return d((a+"-webkit- ".split(" ").join(b+a)+x.join(c+a)).slice(0,-a.length)),g(t.backgroundImage,"gradient")},C.cssreflections=function(){return j("boxReflect")},C.csstransforms=function(){return!!j("transform")},C.csstransforms3d=function(){var a=!!j("perspective");return a&&"webkitPerspective"in q.style&&H("@media (transform-3d),(-webkit-transform-3d){#modernizr{left:9px;position:absolute;height:3px;}}",function(b){a=9===b.offsetLeft&&3===b.offsetHeight}),a},C.csstransitions=function(){return j("transition")},C.fontface=function(){var a;return H('@font-face {font-family:"font";src:url("https://")}',function(c,d){var e=b.getElementById("smodernizr"),f=e.sheet||e.styleSheet,g=f?f.cssRules&&f.cssRules[0]?f.cssRules[0].cssText:f.cssText||"":"";a=/src/i.test(g)&&0===g.indexOf(d.split(" ")[0])}),a},C.generatedcontent=function(){var a;return H(["#",r,"{font:0/0 a}#",r,':after{content:"',v,'";visibility:hidden;font:3px/1 a}'].join(""),function(b){a=b.offsetHeight>=3}),a},C.video=function(){var a=b.createElement("video"),c=!1;try{(c=!!a.canPlayType)&&(c=new Boolean(c),c.ogg=a.canPlayType('video/ogg; codecs="theora"').replace(/^no$/,""),c.h264=a.canPlayType('video/mp4; codecs="avc1.42E01E"').replace(/^no$/,""),c.webm=a.canPlayType('video/webm; codecs="vp8, vorbis"').replace(/^no$/,""))}catch(d){}return c},C.audio=function(){var a=b.createElement("audio"),c=!1;try{(c=!!a.canPlayType)&&(c=new Boolean(c),c.ogg=a.canPlayType('audio/ogg; codecs="vorbis"').replace(/^no$/,""),c.mp3=a.canPlayType("audio/mpeg;").replace(/^no$/,""),c.wav=a.canPlayType('audio/wav; codecs="1"').replace(/^no$/,""),c.m4a=(a.canPlayType("audio/x-m4a;")||a.canPlayType("audio/aac;")).replace(/^no$/,""))}catch(d){}return c},C.localstorage=function(){try{return localStorage.setItem(r,r),localStorage.removeItem(r),!0}catch(a){return!1}},C.sessionstorage=function(){try{return sessionStorage.setItem(r,r),sessionStorage.removeItem(r),!0}catch(a){return!1}},C.webworkers=function(){return!!a.Worker},C.applicationcache=function(){return!!a.applicationCache},C.svg=function(){return!!b.createElementNS&&!!b.createElementNS(B.svg,"svg").createSVGRect},C.inlinesvg=function(){var a=b.createElement("div");return a.innerHTML="<svg/>",(a.firstChild&&a.firstChild.namespaceURI)==B.svg},C.smil=function(){return!!b.createElementNS&&/SVGAnimate/.test(w.call(b.createElementNS(B.svg,"animate")))},C.svgclippaths=function(){return!!b.createElementNS&&/SVGClipPath/.test(w.call(b.createElementNS(B.svg,"clipPath")))};for(var L in C)m(C,L)&&(l=L.toLowerCase(),o[l]=C[L](),F.push((o[l]?"":"no-")+l));return o.input||k(),o.addTest=function(a,b){if("object"==typeof a)for(var d in a)m(a,d)&&o.addTest(d,a[d]);else{if(a=a.toLowerCase(),o[a]!==c)return o;b="function"==typeof b?b():b,"undefined"!=typeof p&&p&&(q.className+=" "+(b?"":"no-")+a),o[a]=b}return o},d(""),s=u=null,function(a,b){function c(a,b){var c=a.createElement("p"),d=a.getElementsByTagName("head")[0]||a.documentElement;return c.innerHTML="x<style>"+b+"</style>",d.insertBefore(c.lastChild,d.firstChild)}function d(){var a=s.elements;return"string"==typeof a?a.split(" "):a}function e(a){var b=r[a[p]];return b||(b={},q++,a[p]=q,r[q]=b),b}function f(a,c,d){if(c||(c=b),k)return c.createElement(a);d||(d=e(c));var f;return f=d.cache[a]?d.cache[a].cloneNode():o.test(a)?(d.cache[a]=d.createElem(a)).cloneNode():d.createElem(a),!f.canHaveChildren||n.test(a)||f.tagUrn?f:d.frag.appendChild(f)}function g(a,c){if(a||(a=b),k)return a.createDocumentFragment();c=c||e(a);for(var f=c.frag.cloneNode(),g=0,h=d(),i=h.length;i>g;g++)f.createElement(h[g]);return f}function h(a,b){b.cache||(b.cache={},b.createElem=a.createElement,b.createFrag=a.createDocumentFragment,b.frag=b.createFrag()),a.createElement=function(c){return s.shivMethods?f(c,a,b):b.createElem(c)},a.createDocumentFragment=Function("h,f","return function(){var n=f.cloneNode(),c=n.createElement;h.shivMethods&&("+d().join().replace(/[\w\-]+/g,function(a){return b.createElem(a),b.frag.createElement(a),'c("'+a+'")'})+");return n}")(s,b.frag)}function i(a){a||(a=b);var d=e(a);return!s.shivCSS||j||d.hasCSS||(d.hasCSS=!!c(a,"article,aside,dialog,figcaption,figure,footer,header,hgroup,main,nav,section{display:block}mark{background:#FF0;color:#000}template{display:none}")),k||h(a,d),a}var j,k,l="3.7.0",m=a.html5||{},n=/^<|^(?:button|map|select|textarea|object|iframe|option|optgroup)$/i,o=/^(?:a|b|code|div|fieldset|h1|h2|h3|h4|h5|h6|i|label|li|ol|p|q|span|strong|style|table|tbody|td|th|tr|ul)$/i,p="_html5shiv",q=0,r={};!function(){try{var a=b.createElement("a");a.innerHTML="<xyz></xyz>",j="hidden"in a,k=1==a.childNodes.length||function(){b.createElement("a");var a=b.createDocumentFragment();return"undefined"==typeof a.cloneNode||"undefined"==typeof a.createDocumentFragment||"undefined"==typeof a.createElement}()}catch(c){j=!0,k=!0}}();var s={elements:m.elements||"abbr article aside audio bdi canvas data datalist details dialog figcaption figure footer header hgroup main mark meter nav output progress section summary template time video",version:l,shivCSS:m.shivCSS!==!1,supportsUnknownElements:k,shivMethods:m.shivMethods!==!1,type:"default",shivDocument:i,createElement:f,createDocumentFragment:g};a.html5=s,i(b)}(this,b),o._version=n,o._prefixes=x,o._domPrefixes=A,o._cssomPrefixes=z,o.mq=I,o.hasEvent=J,o.testProp=function(a){return h([a])},o.testAllProps=j,o.testStyles=H,o.prefixed=function(a,b,c){return b?j(a,b,c):j(a,"pfx")},q.className=q.className.replace(/(^|\s)no-js(\s|$)/,"$1$2")+(p?" js "+F.join(" "):""),o}(this,this.document);

      // GA Segmentation
      window._gaq = window._gaq || []; _gaq.push(['_setAccount', 'UA-2330466-1']);_gaq.push(['_setDomainName', '.slideshare.net']);_gaq.push(['_addIgnoredRef', 'slideshare.net']);_gaq.push(['_setCustomVar', 1, 'member_type', 'LOGGEDOUT', 1]);
        _gaq.push(['_trackPageview']);

      // Comscore
      var _comscore = _comscore || [];
      _comscore.push({ c1: "2", c2: "6402952" });

      // Slideshare object
      var slideshare_object = {
        user: {"is_valid_fbuser":false,"is_test_user":false,"show_li_connect_cta":false,"is_pro":"false","login":"guest","id":null,"name":null,"li_tracking_url":"https://www.linkedin.com/li/track","fb_userid":null,"has_uploads":null,"userGroup":"non-member","su":false,"is_li_connected":false,"loggedin":false,"has_privacy_enabled":null},
        timer: { start: (new Date()).getTime(), end: '', execTime: '' },
        top_nav: { get_url: "/top_nav"},
        dev: false,
        init: [],
        feature_flag: [],
        is_mobile: "",
        deploy_environment: "production",
        rum_pagekey: "desktop_slideview_loggedout",
        is_ssl: false
      };
    </script>

    <meta content="http://public.slidesharecdn.com/b/images/artdeco/icons.svg?43e81fd2ef" name="ss-svg-icons" />

    <script src="http://public.slidesharecdn.com/b/ss_foundation/combined_experiments.js?59e3c7a1df" type="text/javascript"></script>

    

      <link rel="dns-prefetch" href="//js.bizographics.com">
  <script id="adQueue" type="text/javascript"><!--
 if(!slideshare_object.delayedLIAd){ slideshare_object._adQueue = []; } 
//--></script>
  <script type="text/javascript" id="ga-init">
  // <![CDATA[
    // Setting custom variable [slot = 3, scope = 3(page level)] for tracking source (related, search etc) of pageview
    window._gaq.push(['_setCustomVar', 3, 'source', 'not_set', 3]);
    window._gaq.push(['_trackEvent', 'bigfoot_slideview', 'pageload', slideshare_object.gam_cat_name, undefined, true]);

  // ]]>
    <!--
 slideshare_object.deploy_environment = 'production'; 
//-->
  </script>
    <link href="http://www.slideshare.net/harshadoddihal/hta-uncovered-february-2014-31757069" rel="canonical" />
  <link title="Slideshow json oEmbed Profile" type="application/json+oembed" href="http://www.slideshare.net/api/oembed/2?format=json&amp;url=http://www.slideshare.net/harshadoddihal/hta-uncovered-february-2014-31757069" rel="alternate" />
  <link title="Slideshow xml oEmbed Profile" type="text/xml+oembed" href="http://www.slideshare.net/api/oembed/2?format=xml&amp;url=http://www.slideshare.net/harshadoddihal/hta-uncovered-february-2014-31757069" rel="alternate" />
  <link media="handheld" href="http://www.slideshare.net/mobile/harshadoddihal/hta-uncovered-february-2014-31757069" rel="alternate" />

  <meta name="apple-itunes-app" content="app-id=917418728, affiliate-data=ct=smart_banner&amp;pt=10746, app-argument=slideshare-app://ss/31757069"/>
  <link rel="manifest" href="/manifest.json"/>


  <!-- fb open graph meta tags -->
    <meta content="2490221586" class="fb_og_meta" property="fb:app_id" name="fb_app_id" />
    <meta content="slideshare:presentation" class="fb_og_meta" property="og:type" name="og_type" />
      <meta content="http://www.slideshare.net/harshadoddihal/hta-uncovered-february-2014-31757069" class="fb_og_meta" property="og:url" name="og_url" />
    <meta content="http://cdn.slidesharecdn.com/ss_thumbnails/htauncoveredfebruary2014-140228051012-phpapp02-thumbnail-4.jpg?cb=1393564255" class="fb_og_meta" property="og:image" name="og_image" />
    <!-- SL:start:notranslate -->
    <meta content="HTA Uncovered february 2014" class="fb_og_meta" property="og:title" name="og_title" />
    <meta content="HTA Uncovered Is s u e N o. 4 – Fe br ua r y 2 0 14 Impact of accountable-care organizations on biopharmaceutical reimbursement and access Accountable care org…" class="fb_og_meta" property="og:description" name="og_description" />
    <!-- SL:end:notranslate -->
    <meta content="2014-02-28T05:10:12Z" class="fb_og_meta" property="slideshare:published" name="slideshow_published_time" />
    <meta content="http://www.slideshare.net/harshadoddihal" class="fb_og_meta" property="slideshare:author" name="slideshow_author" />
    <meta content="384" class="fb_og_meta" property="slideshare:view_count" name="slideshow_view_count" />
    <meta content="3" class="fb_og_meta" property="slideshare:embed_count" name="slideshow_embed_count" />
    <meta content="0" class="fb_og_meta" property="slideshare:comment_count" name="slideshow_comment_count" />
    <meta content="11" class="fb_og_meta" property="slideshare:download_count" name="slideshow_download_count" />
    <meta content="2014-02-28 05:10:12 UTC" class="fb_og_meta" property="slideshare:created_at" name="slideshow_created_at" />
    <meta content="2014-02-28 05:10:55 UTC" class="fb_og_meta" property="slideshare:updated_at" name="slideshow_updated_at" />
    <meta content="" class="fb_og_meta" property="slideshare:featured_on" name="slideshow_featured_on" />
    <meta content="1" class="fb_og_meta" property="slideshare:favorites_count" name="slideshow_favorites_count" />
    <meta content="" class="fb_og_meta" property="slideshare:category" name="slideshow_category" />

  <!-- SL:start:notranslate -->
    <meta name="twitter:card" value="player" />
    <meta name="twitter:site" value="@slideshare" />
    <meta class="twitter_player" value="https://www.slideshare.net/slideshow/embed_code/key/A18dV3hfktsQNl" name="twitter:player" />
    <meta name="twitter:player:width" value="342" />
    <meta name="twitter:player:height" value="291" />
    <meta class="twitter_title" value="HTA Uncovered february 2014" name="twitter:title" />
    <meta class="twitter_image" value="https://cdn.slidesharecdn.com/ss_thumbnails/htauncoveredfebruary2014-140228051012-phpapp02-thumbnail-4.jpg?cb=1393564255" name="twitter:image" />
    <meta name="twitter:app:name:googleplay" content="SlideShare Android"/>
    <meta name="twitter:app:id:googleplay" content="net.slideshare.mobile"/>
    <meta name="twitter:app:url:googleplay" content="http://www.slideshare.net/harshadoddihal/hta-uncovered-february-2014-31757069" />
    <meta name="twitter:app:name:iphone" content="SlideShare iOS" />
    <meta name="twitter:app:id:iphone" content="917418728" />
    <meta name="twitter:app:url:iphone" content="slideshare-app://ss/31757069" />
    <meta name="twitter:app:name:ipad" content="SlideShare iOS" />
    <meta name="twitter:app:id:ipad" content="917418728" />
    <meta name="twitter:app:url:ipad" content="slideshare-app://ss/31757069" />

  <meta property="al:android:url" content="slideshare-app://ss/31757069" />
  <meta property="al:android:app_name" content="SlideShare Android" />
  <meta property="al:android:package" content="net.slideshare.mobile" />
  <meta property="al:ios:url" content="slideshare-app://ss/31757069" />
  <meta property="al:ios:app_store_id" content="917418728" />
  <meta property="al:ios:app_name" content="SlideShare iOS" />
  <!-- SL:end:notranslate -->

  </head>

  <body id="pagekey-slideshare_desktop_slideview_loggedout" class="   locale-en">
      <!-- TOS update banner -->
      <div class="j-tos-update-banner tos-update-banner" style="display: none;">
  <button class="j-tos-close tos-close fa fa-times-circle"></button>
  <div class="text-div">
    <p class="j-mobile-text mobile-text" style="display: none;">
      Slideshare uses cookies to improve functionality and performance, and to provide you with relevant advertising. If you continue browsing the site, you agree to the use of cookies on this website. See our <a target="_blank" href="http://www.linkedin.com/legal/user-agreement">User Agreement</a> and <a target="_blank" href="http://www.linkedin.com/legal/privacy-policy">Privacy Policy</a>.
    </p>
    <p class="j-desktop-text desktop-text" style="display: none;">
      Slideshare uses cookies to improve functionality and performance, and to provide you with relevant advertising. If you continue browsing the site, you agree to the use of cookies on this website. See our <a target="_blank" href="http://www.linkedin.com/legal/privacy-policy">Privacy Policy</a> and <a target="_blank" href="http://www.linkedin.com/legal/user-agreement">User Agreement</a> for details.
    </p>
  </div>
</div>




      <div id="main-nav" class="contain-to-grid fixed">
        <div class="icon-bar four-up hide-for-medium-up icon-bar-custom">
          <a class="item" href="/" aria-labelledby="#home">
            <i class="icon-slideshare-logo"></i>
            <label id="home">SlideShare</label>
          </a>
          <a class="item" href="/explore" aria-labelledby="#explore">
            <i class="fa fa-compass"></i>
            <label id="explore">Explore</label>
          </a>
          <a class="item j-open-mobile-search" aria-labelledby="#search">
            <i class="fa fa-search"></i>
            <label id="search">Search</label>
          </a>
            <a class="item" class="void_fancybox void_redirect_link" href="https://www.slideshare.net/login" aria-labelledby="#you">
              <i class="fa fa-user"></i>
              <label id="you">You</label>
            </a>
        </div>


        <nav class="top-bar visible-for-medium-up" data-topbar>
          <ul class="title-area">
            <li class="name">
              <a href="/">
                <img id="main-navbar-logo" alt="LinkedIn SlideShare" src="http://public.slidesharecdn.com/b/images/logo/linkedin-ss/SS_Logo_White_Large.png?6d1f7a78a6">
              </a>
            </li>
          </ul>

          <section class="top-bar-section">
            <ul class="right upload-create button-group">
              <li class="has-form upload-create">
                <a href="/upload" class="button radius secondary">Upload</a>
              </li>

                <li>
                  <a href="https://www.slideshare.net/login" class="void_fancybox void_redirect_link" id="login">Login</a>
                </li>
                <li>
                  <a href="https://www.slideshare.net/signup" class="void_fancybox void_redirect_link" id="signup" title="Signup now for a SlideShare account">Signup</a>
                </li>
            </ul>

            <ul class="left">
              <li class="divider"></li>
              <li id="nav-search" class="has-form">
                <form id="nav-search-form" method="get" action="/search/slideshow">
                  <div class="input-box">
                  <input name="searchfrom" type="hidden" value="header">
                    <input id="nav-search-query" type="text" placeholder="Search" name="q" value="" autocomplete="off">
                    <button class="button expand" type="submit"><i class="fa fa-search"></i></button>
                    <ul class='search-suggestions dropdown f-dropdown medium' style="display:none;"></ul>
                  </div>
                </form>
              </li>
            </ul>
          </section>
        </nav>

          <div class="visible-for-medium-up sub-navbar">
            <div class="row">
              <div class="container">
                <ul class="sub-nav-cats left">
                    <li class="sub-nav-cat">
                      <a href="/" class="sub-nav-link" data-ga-action="click" data-ga-cat="sub_nav_cat" data-ga-label="Home" rel="nofollow">Home</a>
                    </li>
                    <li class="sub-nav-cat">
                      <a href="/featured/category/technology" class="sub-nav-link" data-ga-action="click" data-ga-cat="sub_nav_cat" data-ga-label="Technology" rel="nofollow">Technology</a>
                    </li>
                    <li class="sub-nav-cat">
                      <a href="/featured/category/education" class="sub-nav-link" data-ga-action="click" data-ga-cat="sub_nav_cat" data-ga-label="Education" rel="nofollow">Education</a>
                    </li>
                    <li class="sub-nav-cat">
                      <a href="/explore" class="sub-nav-link" data-ga-action="click" data-ga-cat="sub_nav_cat" data-ga-label="More Topics" rel="nofollow">More Topics</a>
                    </li>
                </ul>
                <ul class="sub-nav-cats right show-for-large-up sub-nav-link-ctas">
                  <li class="sub-nav-cat has-dropdown creators-hub-dropdown" data-dropdown="creators-hub-dropdown" data-options="is_hover:true;">
                    <a href="/ss/creators?from=sub-nav" class="sub-nav-link creators-hub" data-ga-action="click" data-ga-cat="sub_nav_cat" data-ga-label="creators_hub">For Uploaders</a>
                  </li>
                </ul>
                <ul id="creators-hub-dropdown" class="dropdown f-dropdown creators-hub-dropdown" data-dropdown-content>
                  <li>
                    <a href="/ss/creators/get-started?from=sub-nav"
                    data-ga-cat="sub_nav_cat"
                    data-ga-action="click"
                    data-ga-label="creators_hub_gs"
                    rel="nofollow">
                    Get Started</a>
                  </li>
                  <li class="divider"></li>
                  <li>
                    <a href="/ss/creators/tips-and-tricks?from=sub-nav"
                    data-ga-cat="sub_nav_cat"
                    data-ga-action="click"
                    data-ga-label="creators_hub_tat"
                    rel="nofollow">
                    Tips & Tricks</a>
                  </li>
                  <li class="divider"></li>
                  <li>
                    <a href="/ss/creators/tools?from=sub-nav"
                    data-ga-cat="sub_nav_cat"
                    data-ga-action="click"
                    data-ga-label="creators_hub_tools"
                    rel="nofollow">
                    Tools</a>
                  </li>
                </ul>
              </div>
            </div>
          </div>
      </div>

    <div class="wrapper">
        <div id="main-nav-mobile-search">
          <form name="mobile-search" action="/search/slideshow" method="get">
           <div class="input-box">
              <input type="text" placeholder="Search" name="q" value="" autocomplete="off">
              <a class="button expand">
                <i class="search-icon fa fa-search"></i>
                <i class="search-spinner fa fa-spinner fa-spin"></i>
              </a>
            </div>
          </form>
        </div>
        


      

      




<iframe id="download" style="display:none" src="" class="notify"></iframe>
<div id="j-downloading-alert" data-alert class="alert-box success radius
downloading-alert">
  <span class="copy-in-aria-label" aria-label="Your SlideShare is downloading."></span>
  <a href="#" class="close copy-in-aria-label" aria-label="&times;"></a>
</div>





<div id="slideview-container" class="">
  <div class="slideview-header-container row">
    <div class="columns">




      <div></div>
    </div>
  </div>

  <div class="row">

    <div id="main-panel" class="small-12 large-8 columns">


      <div class="sectionElements">


        <div class="playerWrapper">



            <div>
              <!-- For slideview page , combined js for player is now combined with slideview javascripts for logged out users-->


<div class="player lightPlayer fluidImage document_player" id="svPlayerId">
  <span class="j-fullscreen-title-banner fullscreen-title-banner" style="display: none;">
    HTA Uncovered february 2014
  </span>

  <div class="stage valign-first-slide">
    <div class="player-cta-container">
    </div>
    <a class="exit-fullscreen j-exit-fullscreen" style="display: none;">
      <i class="fa fa-compress fa-2x"></i>
    </a>
    <div class="slide_container">
            <section data-index="1"  class="slide show" itemprop=image>
                <img class="slide_image"
                  src="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/95/hta-uncovered-february-2014-1-638.jpg?cb=1393564255"
                  data-small="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/85/hta-uncovered-february-2014-1-320.jpg?cb=1393564255"
                  data-normal="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/95/hta-uncovered-february-2014-1-638.jpg?cb=1393564255"
                  data-full="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/95/hta-uncovered-february-2014-1-1024.jpg?cb=1393564255"
                  alt="HTA Uncovered
Is s u e N o. 4 – Fe br ua r y 2 0 14

Impact of accountable-care
organizations on
biopharmaceutical
reimbur..."/>
            </section>
            <section data-index="2"  class="slide" >
                <i class="fa fa-spinner fa-spin"></i>
                <img class="slide_image"
                  src=""
                  data-small="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/85/hta-uncovered-february-2014-2-320.jpg?cb=1393564255"
                  data-normal="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/95/hta-uncovered-february-2014-2-638.jpg?cb=1393564255"
                  data-full="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/95/hta-uncovered-february-2014-2-1024.jpg?cb=1393564255"
                  alt="HTA U nco v e red : Is s u e N o. 4 - F e bru ar y 2 0 14
understand how and to what extent ACO models will
impact accepta..."/>
            </section>
            <section data-index="3"  class="slide" >
                <i class="fa fa-spinner fa-spin"></i>
                <img class="slide_image"
                  src=""
                  data-small="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/85/hta-uncovered-february-2014-3-320.jpg?cb=1393564255"
                  data-normal="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/95/hta-uncovered-february-2014-3-638.jpg?cb=1393564255"
                  data-full="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/95/hta-uncovered-february-2014-3-1024.jpg?cb=1393564255"
                  alt="HTA U nco v e red : Is s u e N o. 4 - F e bru ar y 2 0 14

The introduction and use of HTA

study in postgraduate training..."/>
            </section>
            <section data-index="4"  class="slide" >
                <i class="fa fa-spinner fa-spin"></i>
                <img class="slide_image"
                  src=""
                  data-small="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/85/hta-uncovered-february-2014-4-320.jpg?cb=1393564255"
                  data-normal="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/95/hta-uncovered-february-2014-4-638.jpg?cb=1393564255"
                  data-full="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/95/hta-uncovered-february-2014-4-1024.jpg?cb=1393564255"
                  alt="HTA U nco v e red : Is s u e N o. 4 - F e bru ar y 2 0 14
most cost-effective option should be selected as a
comparator
 ..."/>
            </section>
            <section data-index="5"  class="slide" >
                <i class="fa fa-spinner fa-spin"></i>
                <img class="slide_image"
                  src=""
                  data-small="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/85/hta-uncovered-february-2014-5-320.jpg?cb=1393564255"
                  data-normal="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/95/hta-uncovered-february-2014-5-638.jpg?cb=1393564255"
                  data-full="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/95/hta-uncovered-february-2014-5-1024.jpg?cb=1393564255"
                  alt="HTA U nco v e red : Is s u e N o. 4 - F e bru ar y 2 0 14
Background
India alone accounts for 21% of the world’s global bu..."/>
            </section>
            <section data-index="6"  class="slide" >
                <i class="fa fa-spinner fa-spin"></i>
                <img class="slide_image"
                  src=""
                  data-small="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/85/hta-uncovered-february-2014-6-320.jpg?cb=1393564255"
                  data-normal="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/95/hta-uncovered-february-2014-6-638.jpg?cb=1393564255"
                  data-full="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/95/hta-uncovered-february-2014-6-1024.jpg?cb=1393564255"
                  alt="HTA U nco v e red : Is s u e N o. 4 - F e bru ar y 2 0 14

HTA figures around the globe during
2012-2013
Digging into our ..."/>
            </section>
            <section data-index="7"  class="slide" >
                <i class="fa fa-spinner fa-spin"></i>
                <img class="slide_image"
                  src=""
                  data-small="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/85/hta-uncovered-february-2014-7-320.jpg?cb=1393564255"
                  data-normal="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/95/hta-uncovered-february-2014-7-638.jpg?cb=1393564255"
                  data-full="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/95/hta-uncovered-february-2014-7-1024.jpg?cb=1393564255"
                  alt="HTA U nco v e red : Is s u e N o. 4 - F e bru ar y 2 0 14

Upcoming publications and events
 Meet us at the Pharma Pricin..."/>
            </section>
            <section data-index="8"  class="slide" >
                <i class="fa fa-spinner fa-spin"></i>
                <img class="slide_image"
                  src=""
                  data-small="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/85/hta-uncovered-february-2014-8-320.jpg?cb=1393564255"
                  data-normal="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/95/hta-uncovered-february-2014-8-638.jpg?cb=1393564255"
                  data-full="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/95/hta-uncovered-february-2014-8-1024.jpg?cb=1393564255"
                  alt="HTA U nco v e red : Is s u e N o. 4 - F e bru ar y 2 0 14

More information about
Quintiles’ HTA Solutions
HTA Watch
Quint..."/>
            </section>
        <div class="j-next-container next-container">
          <div class="content-container">
            <div class="next-slideshow-wrapper">
              <div class="j-next-slideshow next-slideshow">
                <div class="title-container">
                  <span class="title-text">Upcoming SlideShare</span>
                </div>
                <div class="j-next-url info">
                  <div class="thumb-container">
                    <img class="j-next-thumb thumb" />
                  </div>
                  <div class="text-container">
                    <span class="j-next-title next-title"></span>
                  </div>
                </div>
              </div>
              <div class="next-timer">Loading in …<span class="j-timer-count timer-count">5</span></div>
              <div class="j-next-cancel next-cancel">&#215;</div>
            </div>
          </div>
        </div>
    </div>
  </div> <!-- end stage -->

  <div class="toolbar_wrapper j-player-toolbar">
    <div class="toolbar normal">
      
<!-- using div.bar-[top, bottom]-margin to fix toolbar spacing with a taller progressbar (improve slide scrubbing UX) -->
<div class="j-progress-bar progress-bar-wrapper">
  <div class="progress-bar-spacing"></div>
  <div class="buffered-bar"></div>
  <div class="j-slides-loaded-bar progress-bar"></div>
  <div class="j-progress-tooltip progress-tooltip" style="display: none;">
    <div class="j-tooltip-content progress-tooltip-wrapper">
      <img class="j-tooltip-thumb tooltip-thumb" onerror="this.src=''"
            slide-thumb-1="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/85/hta-uncovered-february-2014-1-320.jpg?cb=1393564255"
            slide-thumb-2="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/85/hta-uncovered-february-2014-2-320.jpg?cb=1393564255"
            slide-thumb-3="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/85/hta-uncovered-february-2014-3-320.jpg?cb=1393564255"
            slide-thumb-4="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/85/hta-uncovered-february-2014-4-320.jpg?cb=1393564255"
            slide-thumb-5="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/85/hta-uncovered-february-2014-5-320.jpg?cb=1393564255"
            slide-thumb-6="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/85/hta-uncovered-february-2014-6-320.jpg?cb=1393564255"
            slide-thumb-7="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/85/hta-uncovered-february-2014-7-320.jpg?cb=1393564255"
            slide-thumb-8="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/85/hta-uncovered-february-2014-8-320.jpg?cb=1393564255"
      >
      <span class="j-slidecount-label slidecount-label">1</span>
    </div>
    <div class="progress-tooltip-caret"></div>
  </div>
</div>
<div class="progress-bar-spacing"></div>



<div class="j-tools bot-actions">
</div><!-- .bot-actions -->


  <div class="j-tools bot-actions">
    <a data-tooltip
      aria-haspopup="true"
      style="display: none"
      class="j-tooltip j-download action-download has-tip"
      title="Save this document"
      href="/login?from_source=%2Fharshadoddihal%2Fhta-uncovered-february-2014-31757069%3Ffrom_action%3Dsave&amp;from=download&amp;layout=foundation"
      data-target="#login_modal"
      data-placement="top">
      <i class="fa fa-download fa-lg" style="margin-top: 1px;"></i>
    </a>
  </div>




  <div class="nav">
      <button id="btnPrevious" title="Previous Slide">
        <div class="j-prev-btn arrow-left disabled"></div>
      </button>
    <label class="goToSlideLabel">
      <span id="current-slide" class="j-current-slide">1</span> of <span id="total-slides" class="j-total-slides">8</span>
    </label>
      <button id="btnNext" title="Next Slide">
        <div class="j-next-btn arrow-right"></div>
      </button>
  </div>



<div class="navActions">

    <div class="docActions">
      <button id="btnZoomIn" class="j-tooltip btnZoomIn" title="Zoom In">
        <i class="fa fa-plus fa-lg"></i>
      </button>
      <button id="btnZoomOut" class="j-tooltip btnZoomOut" title="Zoom Out">
        <i class="fa fa-minus fa-lg"></i>
      </button>
    </div>


    <button id="btnFullScreen" class="j-tooltip btnFullScreen" title="View Fullscreen">
      <span class="fa fa-stack">
        <i class="fa fa-expand fa-stack-1x"></i>
      </span>
    </button>
    <button id="btnLeaveFullScreen" class="j-tooltip btnLeaveFullScreen" title="Exit Fullscreen">
      <span class="fa-stack">
        <i class="fa fa-compress fa-stack-1x"></i>
      </span>
    </button>

</div>


    </div>
  </div>

  <div class="success-toast-wrapper hide"></div>

  <div class="image_maps"></div>
</div>

<div id="j-lead-form-placeholder" style="display:none">
</div>

            </div>
        </div>

        <div id="lastScreen" style="display: none;">
          <div class="lastScreen">
  <div class="jsplLastScreenOverlay j-last-screen-overlay"></div>
  <div class="pro-overlay j-lastscreen">
    <div class="proSharingText">Like this document? Why not share!</div>
    <ul class="lastActions j-last-screen-actions">
      <li class="share-cta j-share-cta lastscreen-share-cta"><a class="share-btn"><span class="lastScreen-sprite"></span>Share</a></li>
      <li class="email-cta j-email-cta"><a class="email-btn"><span class="lastScreen-sprite"></span>Email</a></li>
      <li class="replay last">
        <a class="replay-btn lastScreenReplay j-tooltip j-last-screen-replay" data-original-title="View again" title="View again">
          <span class="lastScreen-sprite">&nbsp;</span>
        </a>
      </li>
      <li class="close-btn lastScreen-sprite j-lastscreen-close">
        <a>&nbsp;</a>
      </li>
    </ul>
    <div class="related-presentations j-lastscreen-related">
      <ul class="presentation-list">
        <li>
         <a href="/Mediclever/a-shortcut-to-medical-device-reimbursement-in-germany" title="A Shortcut to Medical Device Reimbu..." >
           <img class="j-thumbnail" data-original="//cdn.slidesharecdn.com/ss_thumbnails/5-101123080940-phpapp01-thumbnail.jpg?cb=1422631231" alt="A Shortcut to Medical Device Reimbu..." />
           <span class="presentation-meta">
             <span class="title">A Shortcut to Medical Device Reimbu...</span>
             <span class="author">by&nbsp;Amir Inbar</span>
             <span class="view-count">2141&nbsp;views</span>
           </span>
         </a>
        </li>
        <li>
         <a href="/Clapbio/who-11737475" title="Who" >
           <img class="j-thumbnail" data-original="//cdn.slidesharecdn.com/ss_thumbnails/who-120224124103-phpapp02-thumbnail.jpg?cb=1330087946" alt="Who" />
           <span class="presentation-meta">
             <span class="title">Who</span>
             <span class="author">by&nbsp;Clapbio</span>
             <span class="view-count">722&nbsp;views</span>
           </span>
         </a>
        </li>
        <li>
         <a href="/roh46/drugs-10690799" title="Drugs" >
           <img class="j-thumbnail" data-original="//cdn.slidesharecdn.com/ss_thumbnails/drugs-111226083857-phpapp02-thumbnail.jpg?cb=1324888798" alt="Drugs" />
           <span class="presentation-meta">
             <span class="title">Drugs</span>
             <span class="author">by&nbsp;roh46</span>
             <span class="view-count">246&nbsp;views</span>
           </span>
         </a>
        </li>
        <li>
         <a href="/m_gemmill_toyama/revived-academic-talks-2-presentation" title="Rethink the Academic Talk - 2" >
           <img class="j-thumbnail" data-original="//cdn.slidesharecdn.com/ss_thumbnails/revived-academic-talks-2-1223369431796882-9-thumbnail.jpg?cb=1224295777" alt="Rethink the Academic Talk - 2" />
           <span class="presentation-meta">
             <span class="title">Rethink the Academic Talk - 2</span>
             <span class="author">by&nbsp;Marin Gemmill-Toyama</span>
             <span class="view-count">1211&nbsp;views</span>
           </span>
         </a>
        </li>
        <li>
         <a href="/OHENews/defining-innovation-jm-f-june-2013" title="Defining Innovation in Medicines: H..." >
           <img class="j-thumbnail" data-original="//cdn.slidesharecdn.com/ss_thumbnails/defininginnovationjm-fjune2013-130703085957-phpapp01-thumbnail.jpg?cb=1372845809" alt="Defining Innovation in Medicines: H..." />
           <span class="presentation-meta">
             <span class="title">Defining Innovation in Medicines: H...</span>
             <span class="author">by&nbsp;Office of Health ...</span>
             <span class="view-count">2645&nbsp;views</span>
           </span>
         </a>
        </li>
        <li>
         <a href="/OHENews/high-priced-drugs-issues-panel-ispor-beijing-towse-2014" title="Managed Entry Agreements in Asia " >
           <img class="j-thumbnail" data-original="//cdn.slidesharecdn.com/ss_thumbnails/highpriceddrugsissuespanelisporbeijingtowse2014-141002081955-phpapp01-thumbnail.jpg?cb=1412247457" alt="Managed Entry Agreements in Asia " />
           <span class="presentation-meta">
             <span class="title">Managed Entry Agreements in Asia </span>
             <span class="author">by&nbsp;Office of Health ...</span>
             <span class="view-count">1950&nbsp;views</span>
           </span>
         </a>
        </li>
      </ul>
    </div>

  </div> <!-- end of div class pro-overlay -->
  <div class="j-modal-share modal-share mobile-hide" style="display: none;" id="last-screen-modal-share" data-ga-track-category="" data-ga-track-action="">
  <div class="j-modal-popup modal-popup">
    <div class="j-modal-close modal-close"></div>
    <div class="modal-content-wrapper">
      <div class="j-modal-content modal-content" id="modal-content" data-slideshowid="">
        <header class="j-tabs tabs">
          <a id="button-share-tab" class="selected j-button-share-tab">Share SlideShare</a>
          <hr class="divider"/>
        </header>
        <div class="j-share-tab share-tab">
          <div>
            <ul class="j-share-social-list share-social-list" data-canonical-url="http://www.slideshare.net/harshadoddihal/hta-uncovered-february-2014-31757069">
              <li class="facebook" data-network="facebook">
                <div class="social-hover">
                  <a class="share-link" rel="nofollow" data-u="http://www.slideshare.net/harshadoddihal/hta-uncovered-february-2014-31757069" title="Share on Facebook">Facebook</a>
                </div>
              </li>
              <li class="twitter" data-network="twitter">
                <div class="social-hover">
                  <a class="share-link" rel="nofollow"  data-url="http://www.slideshare.net/harshadoddihal/hta-uncovered-february-2014-31757069" data-text="HTA Uncovered february 2014 by @Harshadod" data-related="@Harshadod" data-via="SlideShare" title="Tweet on Twitter">Twitter</a>
                </div>
              </li>
              <li class="linkedin" data-network="linkedin">
                <div class="social-hover">
                  <a class="share-link" rel="nofollow" data-url="http://www.slideshare.net/harshadoddihal/hta-uncovered-february-2014-31757069" data-text="HTA Uncovered february 2014 by Dr.Harsha Doddihal via slideshare" title="Share on Linkedin">LinkedIn</a>
                </div>
              </li>
              <li class="googleplus" data-network="googleplus">
                <div class="social-hover">
                  <a class="share-link" rel="nofollow" data-url="http://www.slideshare.net/harshadoddihal/hta-uncovered-february-2014-31757069" title="Share on Google+">Google+</a>
                </div>
              </li>
            </ul>
          </div>
          <div class="section share-email">
            <span class="header">Email</span>
            <form id="share-email-form" class="j-share-email-form">
              <input id="share-email-to" data-ga="to" class="j-share-email-to j-email-clear j-share-expand-trigger" name="recipients" placeholder="Enter email addresses"></input>
              <div class="share-email-expand j-share-expand">
                <input id="share-email-name" data-ga="name" class="j-share-email-name j-email-clear" name="name" type="text" placeholder="from…"></input>
                <textarea id="share-email-msg" data-ga="msg" class="j-share-email-msg j-email-clear" name="msg" placeholder="add a message…"></textarea>
                <span class="j-email-flash email-flash"></span>
                <input id="share-email-send" data-ga="send" class="j-share-email-send button btn btn-inverse" type="submit" value="Send" />
                <div style="clear:both"></div>
              </div>
            </form>
            <div id="email-sent" class="j-email-sent section"><div>
              <span class="success-text">Email sent successfully!</span></div>
            </div>
          </div>
          <div class="j-share-embed section share-embed">
            <span class="header">Embed</span>
            <textarea id="share-embed-link" class="j-share-embed-link j-share-expand-trigger" readonly data-ga="link"></textarea>
            <div class="share-embed-options j-share-expand">
              <div class="embed-size">
                <span class="title">Size (px)</span>
                <select class="j-embed-size-picker embed-size-picker j-update-embed" id="embed-size-picker" data-ga="size-picker"></select>
              </div>
                <div class="embed-start">
                  <span class="title">Start on</span>
                  <select class="j-embed-start-picker embed-start-picker j-update-embed" id="embed-start-picker" data-ga="start-picker"></select>
                </div>
              <div class="embed-show-related" style="display:none">
                <input type="checkbox" name="related-content" checked="checked" class="j-embed-related-cbox embed-related-cbox j-update-embed" data-ga="related">
                <span>Show related SlideShares at end</span>
              </div>
            </div>
          </div>
          <div class="wordpress-container section">
            <span class="header">WordPress Shortcode</span>
            <input type="text" name="embed-code" id="share-embed-wp" value="" readonly="readonly" class="j-share-embed-wp text quiet h-wpembedcode j-share-expand-trigger" data-ga="wp-link">
          </div>
          <div class="share-link-container section">
            <span class="header">Link</span>
            <input type="input" class="j-share-link-url j-share-expand-trigger" id="share-link-url" data-ga="link" readonly></input>
          </div>
        </div>
      </div>
    </div>
  </div>
</div><!-- share modal -->

</div><!-- last screen ends here -->

        </div>
      </div>

      <div class="slideshow-info-container" itemscope itemtype="http://schema.org/MediaObject">


        <div class="slideshow-info">
          <meta itemprop="inLanguage" content="en">
          <meta itemprop="image" content="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/95/hta-uncovered-february-2014-1-638.jpg?cb=1393564255">
          <meta itemprop="thumbnailUrl" content="http://cdn.slidesharecdn.com/ss_thumbnails/htauncoveredfebruary2014-140228051012-phpapp02-thumbnail.jpg?cb=1393564255">
          <meta itemprop="embedURL" content="https://www.slideshare.net/slideshow/embed_code/key/A18dV3hfktsQNl">
          <meta itemprop="playerType" content="HTML5">
          <meta itemprop="interactionCount" content="UserComments:0">
          <meta itemprop="interactionCount" content="UserLikes:1">
          <meta itemprop="interactionCount" content="UserDownloads:11">
          <meta itemprop="interactionCount" content="UserPageVisits:384">
          <meta itemprop="interactionCount" content="UserPlays:384">
          <meta itemprop="interactionCount" content="UserPlusOnes:0" id="meta-google">
          <meta itemprop="interactionCount" content="UserTweets:0" id="meta-twitter">


          <div class="slideshow-title-container row add-padding-right">
            <div class="small-10 columns">
              <h1 class="notranslate slideshow-title-text" itemprop="headline">
                <span class="j-title-breadcrumb">
                  HTA Uncovered february 2014
                </span>
              </h1>
            </div>

          <div class="small-2 columns text-right format-views">
                <span class="notranslate pippin-data">
                  384 views<br>
                </span>
            </div>
          </div>

          <ul id="slideshow-actions" class="slideshow-actions">
            <li class="item-action">
              <button class="tiny art-deco share" data-action="share">Share</button>
            </li>
              <li class="item-action">
                <button class="tiny art-deco like button" data-action="like" href="/signup?login_source=slideview.popup.like&amp;from=favorite&amp;layout=foundation&amp;from_source=http%3A%2F%2Fwww.slideshare.net%2Fharshadoddihal%2Fhta-uncovered-february-2014-31757069" rel="nofollow">Like</button>
              </li>
              <li class="item-action">
                <button class="tiny art-deco download button" data-action="download" href="/login?from_source=%2Fharshadoddihal%2Fhta-uncovered-february-2014-31757069%3Ffrom_action%3Dsave&amp;from=download&amp;layout=foundation" rel="nofollow">
                  Download
                </button>
              </li>
          </ul>


          <div class="author-container add-padding-right" itemprop="author" itemscope itemtype="http://schema.org/Person">

            <div class="left author-thumbnail">
              <a href="/harshadoddihal?utm_campaign=profiletracking&amp;utm_medium=sssite&amp;utm_source=ssslideview" class="author-photo-wrapper" title="harshadoddihal" itemprop="url">
                <img alt="Dr.Harsha Doddihal" class="author-photo" itemprop="image" src="//cdn.slidesharecdn.com/profile-photo-harshadoddihal-48x48.jpg?cb=1473778890" />
              </a>
            </div>

            <div class="author-text">
              <h2 style="display:inline;">
                <a class="j-author-name"
                  title="harshadoddihal"
                  rel="author"
                  href="/harshadoddihal?utm_campaign=profiletracking&amp;utm_medium=sssite&amp;utm_source=ssslideview"
                  data-ga-cat="bigfoot_slideview"
                  data-ga-action="authorlinkclick">
                  <span itemprop="name">Dr.Harsha Doddihal</span></a></h2><small class="lighter-color-text" itemprop="jobTitle">, Entrepreneur-Helping self &amp; people through healthcare &amp; pharmaceutical maze</small>


              <div class="author-cta-container">

                  <div class="follow-container">
                    <span class="j-follow " data-contactee-id="53349210">

                        <a class="follow-btn" data-contactee="53349210" href="/signup?login_source=slideview.popup.follow&from=addcontact&from_source=http%3A%2F%2Fwww.slideshare.net%2Fharshadoddihal%2Fhta-uncovered-february-2014-31757069">
                          <i class="fa fa-plus"></i> Follow
                        </a>

                      <div class="j-follow-progress indicator">
                        <i class="fa fa-spinner fa-spin"></i>
                      </div>
                    </span>
                  </div>
              </div>
            </div>
          </div>

            <div class="social-share-container add-padding-right">
              <button id="sv-linkedin-share" class="j-share-item button-li tiny radius" data-network="linkedin" data-ga-action="viralshareLinkedIn_click">
                <i class="fa fa-linkedin fa-lg"></i>
                <span class="separator"></span>
                <span class="j-share-count share-count">0</span>
              </button>

              <button id="sv-facebook-share" class="j-share-item button-fb tiny radius" data-network="facebook" data-ga-action="viralsharefacebook">
                <i class="fa fa-facebook fa-lg"></i>
                <span class="separator"></span>
                <span class="j-share-count share-count">0</span>
              </button>

              <button id="sv-twitter-share" class="j-share-item button-tw tiny radius" data-network="twitter" data-ga-action="viralsharetwitter_click">
                <i class="fa fa-twitter fa-lg"></i>
                <span class="separator"></span>
                <span class="j-share-count share-count">0</span>
              </button>
            </div>

          <p>
            <small>
              Published on <time datetime="Feb 28, 2014" itemprop="datePublished">Feb 28, 2014</time>
            </small>
          </p>






        </div>


        <div class="slideshow-tabs-container show-for-medium-up">
          <dl class="tabs" data-tab>
              <dd class="active">
                <a href="#comments-panel">
                  <i class="fa fa-comment"></i>
                    0 Comments
                </a>
              </dd>

            <dd class="">
              <a href="#likes-panel">
                <i class="fa fa-heart"></i>
                <span class="j-favs-count">
                  1 Like
                </span>
              </a>
            </dd>


            <dd>
              <a href="#stats-panel" class="j-stats-tab">
                <i class="fa fa-bar-chart"></i>
                Statistics
              </a>
            </dd>

            <dd>
              <a href="#notes-panel">
                <i class="fa fa-file-text"></i>
                Notes
              </a>
            </dd>
          </dl>

          <div class="tabs-content">

              <div id="comments-panel" class="content active commentsWrapper commentsNotes">
                <ul class="hide">

                  <li id="commentsTemplate">
                    <div class="row">
                      <div class="small-1 columns thumbnail">
                        <a class="j-author-photo notranslate commenter" title="Commenter Title" rel="nofollow">
                          <img class="nickname"
                            alt="Full Name"
                            src="//public.slidesharecdn.com/b/images/user-48x48.png" />
                        </a>
                      </div>

                      <div class="small-11 columns">
                        <a class="j-author-photo notranslate commenter" title="Commenter Title" rel="nofollow">
                          <span class="j-username notranslate" data-ga-cat="bigfoot_slideview" data-ga-action="commentuserlinkclick">Full Name</span>
                          <span class="bioStub notranslate">
                            <span class="j-commenter-role"></span>
                            <span class="j-commenter-org"></span>
                          </span>
                        </a>

                        <div class="commentText notranslate">
                          Comment goes here.
                        </div>

                        <time class="commentTimestamp small-text lighter-color-text">12 hours ago</time>&nbsp;&nbsp;

                        <span class="commentMeta">
                          <span class="commentActions small-text">
                            <a href="#" class="j-action-delete">Delete</a>
                            <a href="#" class="j-reply">Reply</a>
                            <a href="#" class="j-action-spam">Spam</a>
                            <a href="#" class="j-action-block">Block</a>
                          </span>
                        </span>

                        <div id="confirmDialog" class="panel callout block-message">
                          <div>
                            <span class="title">Are you sure you want to</span>
                            <a href="#" id="yes">Yes</a>
                            <a href="#" id="no">No</a>
                          </div>
                        </div>

                        <div id="messageDialog" class="block-message">
                          Your message goes here
                        </div>

                        <span class="j-loading" style="display: none;">
                          <i class="fa fa-spinner fa-spin"></i>
                        </span>
                      </div>
                    </div>
                  </li>
                </ul>


                  <form action="#" method="post" accept-charset="utf-8" id="postComment" class="j-comment-post postComment">
                    <div class="row">
                      <div class="small-1 columns thumbnail">
                          <div class="left">
                            <img class="nickname" alt="no profile picture user"
                              src="//public.slidesharecdn.com/b/images/user-48x48.png" />
                          </div>
                      </div>

                      <div class="small-11 columns">
                        <div class="row collapse">
                          <div class="small-10 columns">
                            <input class="j-post-comment-input comment-text" type="text" placeholder="Share your thoughts…" />
                          </div>
                          <div class="small-2 columns">
                              <a id="login-provider-slideshare" class="postfix" rel="nofollow" href="/signup?login_source=slideview.popup.comment&from=comments&from_source=http%3A%2F%2Fwww.slideshare.net%2Fharshadoddihal%2Fhta-uncovered-february-2014-31757069">
                                <button type="button" class="postfix">Post</button>
                              </a>
                          </div>
                        </div>
                      </div>
                    </div>
                  </form>

                <ul id="commentsList" class="user-list no-bullet">
                    <li>
                      <p class="empty-stat-box text-center">
                        <em>Be the first to comment</em>
                      </p>
                    </li>
                </ul>

              </div>


            <div class="content" id="likes-panel">
              <ul id="favsList" class="j-favs-list notranslate user-list no-bullet" itemtype="http://schema.org/UserLikes" itemscope>
                    <li itemtype="http://schema.org/Person" itemscope>
                      <div class="row">

                        <div class="small-1 columns thumbnail">
                          <a class="j-author-photo notranslate"
                            title="cmmtech"
                            itemprop="url"
                            rel="nofollow"
                            href="/cmmtech?utm_campaign=profiletracking&utm_medium=sssite&utm_source=ssslideshow">

                            <img itemprop="image"
                              class="j-lazy-thumb"
                              alt="cmmtech"
                              src="//public.slidesharecdn.com/b/images/user-48x48.png"
                              data-original="//cdn.slidesharecdn.com/profile-photo-cmmtech-48x48.jpg" />
                          </a>
                        </div>

                        <div class="small-11 columns">

                          <a class="favoriter notranslate"
                            title="cmmtech"
                            rel="nofollow"
                            href="/cmmtech?utm_campaign=profiletracking&utm_medium=sssite&utm_source=ssslideshow">

                            <span class="j-username notranslate" data-ga-cat="bigfoot_slideview" data-ga-action="favoriteuserlinkclick" itemprop="name">Murray Simon</span>
                            <span class="bioStub notranslate small-text light-color-text">
                              <span class="j-favoriter-role">
                                
                                <span></span>
                              </span>
                              <span class="j-favoriter-org">
                                
                                <span></span>
                              </span>
                            </span>

                            <div class="j-tags favTags"></div>

                            <time class="commentTimestamp small-text lighter-color-text">
                              2 years ago
                            </time>
                          </a>
                        </div>
                      </div>
                    </li>
              </ul>

            </div>

            <div class="content" id="downloads-panel">
                <div class="empty-stat-box">No Downloads</div>
            </div>

            <div class="content" id="stats-panel">
              <div class="row info-stats">
                <div class="small-4 columns">
                  <strong>Views</strong>
                  <div class="row">
                    <div class="small-8 columns stat-label">Total views</div>
                    <div class="small-4 columns stat-value text-right">
                      384
                    </div>

                    <div class="small-8 columns stat-label">On SlideShare</div>
                    <div class="j-slideshare-views small-4 columns stat-value text-right ">
                      0
                    </div>

                    <div class="small-8 columns stat-label">From Embeds</div>
                    <div class="j-embed-views small-4 columns stat-value text-right">
                      0
                    </div>

                    <div class="small-8 columns stat-label">Number of Embeds</div>
                    <div class="small-4 columns stat-value text-right">
                      3
                    </div>
                  </div>
                </div>

                <div class="small-4 columns">
                  <strong>Actions</strong>
                  <div class="row">
                    <div class="small-8 columns stat-label">Shares</div>
                    <div class="small-4 columns stat-value text-right j-total-shares">0</div>

                    <div class="small-8 columns stat-label">Downloads</div>
                    <div class="small-4 columns stat-value text-right ">
                      11
                    </div>

                    <div class="small-8 columns stat-label">Comments</div>
                    <div class="small-4 columns stat-value text-right">
                      0
                    </div>

                    <div class="small-8 columns stat-label">Likes</div>
                    <div class="small-4 columns stat-value text-right">
                      1
                    </div>
                  </div>
                </div>

                <div class="small-4 columns">
                  <strong>
                    Embeds
                    <span class="j-embed-views notranslate from-embed hint">0</span>
                  </strong>

                  <div class="j-info-embeds">
                      <div class="j-no-embeds no-embeds">No embeds</div>
                    <div class="row no-translate j-embeds-container" style="max-height:120px; overflow:auto;">
                    </div>
                  </div>
                </div>
              </div>

              <hr>

              <div class="row">
                <div class="small-12 columns">
                  <strong class="copy-in-aria-label" aria-label="Report content"></strong><br>
                  <div class="flag flag-inappropriate">
                    <a class="action-flag" rel="nofollow" href="/signup?login_source=slideview.popup.flags&amp;from=flagss&amp;from_source=http%3A%2F%2Fwww.slideshare.net%2Fharshadoddihal%2Fhta-uncovered-february-2014-31757069">
                      <span class="j-tooltip flagged copy-in-aria-label" title="This Document has been flagged" aria-label="Flagged as inappropriate"></span>
                      <span class="j-tooltip flag copy-in-aria-label" title="Flag this document as inappropriate" aria-label="Flag as inappropriate"></span>
                    </a>
                  </div>

                  <div>
                    <a href="http://www.linkedin.com/legal/copyright-policy" rel="nofollow" class="copy-in-aria-label" aria-label="Copyright Complaint"></a>
                  </div>
                </div>
              </div>
            </div>

            <div class="content" id="notes-panel">
              <div id="empty-note" class="empty-stat-box">No notes for slide</div>
            </div>
          </div>
        </div>

            <div class="notranslate transcript add-padding-right j-transcript"  >
              <h3 class="transcript-header">
                  <i class="fa fa-file-o"></i>
                  HTA Uncovered february 2014
              </h3>
              <ol class="j-transcripts transcripts no-bullet no-style" itemprop="text">
                    <li>
      1.
    HTA Uncovered
Is s u e N o. 4 – Fe br ua r y 2 0 14

Impact of accountable-care
organizations on
biopharmaceutical
reimbursement and access
Accountable care organizations (ACOs)
are a relatively recent phenomenon in
the United States healthcare system,
accelerated by the Patient Protection
and Affordable Care Act (PPACA) of
2009. ACO models generally have three
basic tenets vs. existing fee-for-service
provider health delivery models: (1) they
are accountable for quality and cost
management across the care continuum
for a population of patients; (2)
payments are linked to quality
improvements that reduce overall care
delivery costs; and (3) often involve
sophisticated
performance
measurement to track improvements. In
some models, outside of performance
dashboards, providers are responsible
for managing delivery of core service
groups within a fixed budget, more
pointedly
shifting
burden
of
management from the payer to the
provider.

“It will be critical for
manufacturers to anticipate
the different evidence needs
and decision drivers of at-risk
providers, understand the
extent their products may be

To understand the perceived impact of
ACOs on biopharmaceuticals, specialty
pharmaceuticals, and other high-cost
medical technologies, a survey was
conducted of medical directors at

impacted by ACO approaches,
and develop value
communications aligned with

managed-care
organizations
and
provider groups, with responses from 40
individuals in total. This survey was
supported by Quintiles and sponsored
by the Genomics Biotech Emerging
Medical Technology Institute of National
Association
of
Managed
Care
Physicians, a 10,000+ payer, providers
and healthcare purchasers‟ organization
in the US1.
Eight approaches to health technology
market access were assessed on a
scale of 1-10, with 1 being highly
unlikely and 10 being highly likely. Key
implications of ACO models, from the
perspective of US commercial payers,
are highlighted below (Figure 1).
The results of this survey suggest that
medical directors anticipate that greater
emphasis on clinical pathways and a
heightened level of provider value
scrutiny are likely or highly likely, with
70% to 80% of respondents suggesting
that how technologies fit into care
paradigms and overall levels of
supporting evidence for that fit are likely
to increase in the short term. Along with
this, over 60% of respondents anticipate
that the threshold for acceptance will
increase and potentially influenced
contract terms based upon relative
value assessments. This indicates that
technology manufacturers need to

Figure 1: Extent to which the following outcomes are seen as likely or unlikely for
new technologies as a result of ACO

this new provider
management model.”

Higher access hurdles targeting quality and/or pay
for performance

Eric Faulkner, Director, Global

New contracting requirements

Market Access, Quintiles

38%
32%

Preclude some new health technologies

Consulting and Executive

Clinical pathways for greater cost savings

Director, Genomics Biotech

Clinical pathways for improved efficacy

Emerging Medical Technology
Association of Managed Care

Increased provider scrutiny of value

Physicians

Unlikely
1

68%

54%
32%

46%
68%

22%

Carve-outs for certain HTAs

Institute of the National

62%

78%
64%

28%

36%

72%

Likely

For more information, please contact the study lead author, Eric Faulkner, at eric.faulkner@quintiles.com

 
  </li>
  <li>
      <a href="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/95/hta-uncovered-february-2014-2-638.jpg?cb=1393564255" title="HTA U nco v e red : Is s u e N o. 4 - F e bru ar y 2 0 14
u..." target="_blank">
        2.
      </a>
    HTA U nco v e red : Is s u e N o. 4 - F e bru ar y 2 0 14
understand how and to what extent ACO models will
impact acceptance and uptake of new health
technologies and that framing of value propositions
should consider overall relative value, fit within existing
care pathways, and how providers will increasingly play a
role as gatekeepers to technology access.
Respondents remain uncertain about the likelihood of
ACOs targeting technologies at the extremities of the
value spectrum via carve outs and preclusions. However,
results do suggest that payers and providers in the US
may be more receptive to novel approaches or
partnership terms that fit with evolving business models
and objectives. Contracting approaches, in tandem, may
also evolve compared to more historical static
approaches and terms may be open to innovative

negotiation, including monitoring and further value
demonstration of health technologies that may emerge in
the form of novel data collection approaches and/or
monitoring and management paradigms.
This also suggests that (a) development of a solid product
value story that looks beyond the product and considers
practical implementation in real world care settings
(including anticipation of impacts relevant to at-risk
provider organizations in the US) will become increasingly
important, as will (b) staying in touch with changing
provider requirements as ACO models expand/evolve,
including through early engagement, are cornerstones of
future success (assuming that they consider the
significant heterogeneity of existing models).

Background
The ACO concept is the result of ongoing innovation in the
organization of payer/provider organizations that can be
traced to a 2006 conference presentation given by Dr. Elliot
Fisher of Dartmouth University2. Initial focus of Medicare
performance dashboards centered on but were not limited to
core financial drivers such as cardiovascular disease,
metabolic disease, and diabetes, though some models have
began to emerge in other specialty areas such as oncology3.
Medicare mandated development of ACOs under PPACA
stimulated commercial payer organizations to accelerate this
concept in the mid-2000s, developing more comprehensive
models than those required under Medicare. By early 2013,
more than 40% of Americans lived in primary care service
areas with at least one ACO4. Previous efforts at integration
of payers and providers included the health management
organizations (HMOs) of the 1990s, which failed due to an
imbalanced focus on cost reduction without sufficient
incentives to improve patient outcomes5. Modern ACOs are
keen to avoid making this pitfall6, and do so by making
improvement of care outcomes a top priority along with cost
reduction7. Although they currently comprise small
proportion of the healthcare provider landscape, they are
being carefully watched as incubators for future standards of
care delivery and financial management.
The integration of health technology management into ACO
structures remains an open question, with bio-

pharmaceuticals and specialty pharmaceuticals likely to be
ripe targets for ACO attention due to high up-front costs.
Prior to advent of ACO models and additional focus on more
proscriptive clinical pathways, some of the most important
tools for access management were public and private payer
coverage policy enforcement and contracting – though a
majority of coverage policy development has historically
focused on access management of high cost and/or volume
technologies. ACO models create the opportunity for more
focused performance management, but have heretofore
focused on a somewhat different mix of technologies vs. ACO
dashboards.
At present, initial HTA of emerging technologies remains
within the remit of the payer organizations developing
coverage policies. Alternatively, inclusion of technologies
under ACO models is more proportionally focused on
established technologies whose use is well characterized.
Currently,
ACO
evaluation
of
use
of
new
technologies/services is non-transparent and inclusive of
different business information drivers. Nonetheless,
manufacturers who are interested in the inclusion of
products on ACO formularies have a vested interest in
communicating the economic value of their products in
alignment with the metrics ACOs are evaluated upon (though
many technologies are not yet included in ACO dashboards
and subject to traditional payer management approaches).

NICE to aid implementation of HTA-based decisions in India
A Memorandum of Understanding (MoU) signed between Department of Health Research (DHR) India and NICE on 14 th
June 2013 indicates that Indian health policy makers and payers seem to moving towards a formal HTA process 8. Such
international collaboration may lead to a more active implementation of HTA in India and strengthen India‟s capacity in
the development of health care policy and evidence-based decision-making. NICE has successfully helped other
countries before. For example initial results from a recent pilot project to introduce evidence-based clinical pathways and
payment reform in China&#x27;s rural hospitals9,10 resulted in a signicant drop in unnecessary medical services use without
revenue reduction11.
The MoU signed between NICE and DHR seems to be a step in the right direction. But the task in front of the nation is
challenging and will require significant resources. DHR intends to set up a “Health Technology Assessment Board” and
discusses capacity building by strengthening existing institutions responsible for turning evidence into policy. In addition
to collaboration with NICE, this will require introducing HTA science and pharmacoeconomics as an optional course of
References: 2American Hospital Association. 2010 Committee on Research. AHA Research Synthesis Report: Accountable Care Organization. 3Mehr SR.
Applying accountable care to oncology: developing an oncology ACO. Am J Manag Care. 2013 Mar-Apr;19 Spec No. 3:E2. 4Gandhi N. and Weil R. “The ACO
Surprise”. Oliver Wyman Health and Life Sciences, 2012. 5Coombs, J.G. The rise and fall of HMOs: an American health care revolution. Madison: University of
Wisconsin Press 2005. 6Gold J. FAQ On ACOs: Accountable Care Organizations, Explained. August 23, 2013. 7”Next Steps for ACOs” Health Affairs. 2012.

2

 
  </li>
  <li>
      <a href="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/95/hta-uncovered-february-2014-3-638.jpg?cb=1393564255" title="HTA U nco v e red : Is s u e N o. 4 - F e bru ar y 2 0 14

..." target="_blank">
        3.
      </a>
    HTA U nco v e red : Is s u e N o. 4 - F e bru ar y 2 0 14

The introduction and use of HTA

study in postgraduate training programs
in key medical and pharmacy teaching
institutions across the country. The HTA
Board will, in due course of time, have
to set up a NICE-like HTA center that
will prioritize therapeutic areas and
disease entities for study and set out to
map treatment algorithms informed by
systematic technology assessment.
Academics in India have also been
discussing the possibility to introduce
HTA through a structured quick
assessment
(SQA)
of
all
pharmaceuticals (both patented and
generic) applying for public funding in
India12. The authors recommend to
establish an independent department in
the Drug Controller General‟s office at
Central
Drugs
Standard
Control
Organization in New Delhi to oversee
these assessments.

in healthcare decision-making

HTA in India

in India should be good news for
the pharmaceutical and health
technology industries. It should
make the basis of adoption of
new technologies in the country
more data-driven, transparent
and predictable. Companies will
have to gear up to generate the
data to justify product
positioning and pricing.
Conversely, HTA should help
guide pricing in a market where
companies have sometimes gone
horribly wrong with pricing.
The need for data is likely to
spawn growth in outcomes
research services and
publications and feed demand
for appropriately qualified and
trained personnel”
Shoibal Mukherjee, Vice President
&amp; Head Asia Medical Sciences
Group, Quintiles, India

At present there is no formal HTA
process taking place in India. Many
indirect ways of ensuring value for
money are being used and all
reimbursement decisions are made on a
case-by-case basis by organizations
such as Employee State Insurance
Scheme (ESIS), Central Government
Health Scheme (CGHS), Rashtriya
Swasthya Bima Yojana (RSBY), and
private insurance companies. Table 1
presents an overview of the key public
and state health insurance schemes in
India.
The need to seek value or HTA is not
entrenched in the decision-making
process of these payers as the impact
of reimbursement of patented drugs is
relatively small. The availability of
generic drugs and the so-called notion
of them being affordable has limited the
concept of seeking value. Increasingly
as budgetary reviews are being done,
value for new patented drugs are being
questioned. There is an expectation that
this is set to change in coming years as
more patients receive patented drugs.
The federal price control system could
be better targeted with HTA inputs.
Therapies and technologies that offer
better value for money could be
prioritized over those that offer less net
benefit, and price controls could be
calibrated to optimize overall value of

“Anticipating that in next 3-5
years HTA will become routine in
India, being ahead of the curve
mandates that health economic
endpoints are incorporated in
trials performed in India and
disease-specific or drug classspecific patient registries are
established”
Harsha Doddihal, Associate
Medical Director, Quintiles, India

new
technologies.
Medicines
procurement programs and formularies
could be better managed by application
of HTA, thus providing a better value for
the taxpayer money while setting
procurement standards to put decisionmaking on a firmer footing in line with
pharmacoeconomic logic and away
from arbitrary influences. A formal HTA
will pave way for treatment guidelines,
closer scrutiny of pharmacovigilance
data, and establishment of patient
registries.
HTA reports could also be a valuable
input to other government agencies
tasked
with
public
health
responsibilities. Thus, preventive health
programs run by the federal and state
governments could benefit enormously
from HTAs, as can disease control
programs for endemic diseases such as
malaria, tuberculosis, kala-azar, and
AIDS.
A first step was taken recently when the
ISPOR India Chapter developed and
presented
“Proposed
Pharmacoeconomics
Guidelines
for
India
(PEG-I)”13. The following guidance was
proposed:
 Primary target of
pharmacoeconomic research:
Ministry of Health and Family
Welfare, Government of India
 Perspective: all costs and benefits
from a societal perspective should be
included (irrespective of who actually
bears the costs or receives the
benefits)
 Comparator: ideally, the current
3

 
  </li>
  <li>
      <a href="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/95/hta-uncovered-february-2014-4-638.jpg?cb=1393564255" title="HTA U nco v e red : Is s u e N o. 4 - F e bru ar y 2 0 14
m..." target="_blank">
        4.
      </a>
    HTA U nco v e red : Is s u e N o. 4 - F e bru ar y 2 0 14
most cost-effective option should be selected as a
comparator
 Analytical technique: CUA, CEA, or CMA can be
carried out
 Time horizon: must enable valid and reliable
statements to be made regarding the effects and costs
of the treatments being compared
 Discounting: 3% rate should be considered for both
costs and effects.

“A proactive approach from
pharmaceutical industry in demonstrating
cost-effectiveness is needed to address
purchasing power parity and compulsory
licensing challenges. A recent launch of a
cardiovascular drug which demonstrated

Although HTA is in its infancy in India, the awareness
regarding the costs of interventions does present. A
review of the Centre for Review and Dissemination
database (University of York) revealed that several
pharmacoeconomic studies have been published over the
past 5 years in India. The majority of these studies14-16
focused on communicable diseases like HIV, tuberculosis,
rotavirus, leishmaniasis, which despite socio-economic
development still remain a high burden in the South-East
Asia region17. But also chronic diseases and injuries,
chemotherapy and psoralen have recently been
evaluated18-20. These examples indicate that HTA is
gaining more attention in India and may become part of
standard practice in the near future.

pharmacoeconomic value is an example of
how the future could look like”
Harsha Doddihal, Associate Medical
Director, Quintiles, India

Table 1: Public and state health insurance schemes in India
Type

HI Scheme

Population

No of beneficiaries
(million)

Funding

Benefits package

Public

CGHS

Central government
employees

3

GOI
Beneficiaries

Public

ESIS

Employers
Employees

55.5

Public/State

RSBY

BPL population

131*

Public/State

RSBY Plus
(HP)

BPL population
enrolled in RSBY

NA

Beneficiaries
Employers
State
25% State
75% GOI
100% State

Public/State

ASBY (Delhi)

BPL population
enrolled in RSBY

NA

100% State

Public/State

Rajiv
Aarogyasri
Scheme (AP)
Kalaignar (TN)

BPL but went ahead
to almost the entire
population (85%)
BPL

70

100% State

Outpatient; inpatient;
preventive and ambulatory
services; mainly tertiary
Outpatient; inpatient;
preventive and ambulatory
services; all levels
Inpatient, secondary care;
chronic diseases
Inpatient, tertiary care;
complementary to RSBY
coverage
Inpatient, tertiary care
Complementary to RSBY
coverage
Inpatient, tertiary care;
chronic diseases

Over 50

100% State

Vajapayee
Arogyasri
Scheme (KN)
Yeshasvini
(KN)

BPL

1.6

100% State

Registered in
cooperative
societies, both BPL
and APL

3

40% State
Beneficiaries

Public/State
Public/State

Community/
NGOs

Inpatient, tertiary care;
chronic diseases
Inpatient, secondary and
some tertiary care; chronic
diseases
Outpatient; inpatient tertiary
care; chronic diseases

Source: Reddy KS et al. A Critical Assessment of the Existing Health Insurance Models in India. Public Health Foundation of India. 31 January
2011. *Number of beneficiaries are reported as per 2010, except for RSBY where the calculation of beneficiaries assumes an average of 3.5
members per family enrolled and 37.7 million active cards currently in this scheme.

References: 8UK and India to work together on evidence-informed healthcare policy and practice. 14 June 2013. https://www.gov.uk. 9Cheng TM. A pilot project
using evidence-based clinical pathways and payment reform in China&#x27;s rural hospitals shows early success. Health Aff (Millwood). 2013 May;32(5):963-73. 10NICE.
Supporting the evaluation of Clinical Pathways in rural China. 11Pittman D. Case-Based Pay Pays Off in China. MedPage Today. April 2013. 12ISPOR Asia
Consortium Newsletter. Vol 2 No 3. Sep-Nov 2013. 13ISPOR India Chapter. Draft of proposed Pharmacoeconomics Guidelines for India (PEG - I). Oct 2013.

4

 
  </li>
  <li>
      <a href="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/95/hta-uncovered-february-2014-5-638.jpg?cb=1393564255" title="HTA U nco v e red : Is s u e N o. 4 - F e bru ar y 2 0 14
B..." target="_blank">
        5.
      </a>
    HTA U nco v e red : Is s u e N o. 4 - F e bru ar y 2 0 14
Background
India alone accounts for 21% of the world’s global burden of
disease21 and is the world&#x27;s third-largest pharmaceutical
market in terms of volume22. In 2011, India’s total
expenditure on health as % of GDP was 3.9% (Table 3).
With a continuing increase in healthcare spending by the
Indian government (from 6.7 billion USD in 2005-2006 to
11.7 billion in 2008-2009), as well as number of insured
people increasing from 300 million in 2010 to an estimated
655 million in 202023, both government and private payers
will seek to assess value for money.
In India, health insurance coverage, vaccination, medical
facilities and state reimbursement widely vary from state to
state. The public healthcare system is underdeveloped, with
almost half the population having to travel over 100
kilometers to access an acceptable level of care24. The
majority of Indian population does not have a health
insurance and pays for health care out-of-pocket. Limited
width and depth of health insurance and the lack of a safety
net makes families highly vulnerable to catastrophic
healthcare spending that can wipe out a lifetime of
savings25,26. About 25% of the population is currently
insured, out of which 5% by the Central Government Health
Scheme (CGHS) and Employee State Insurance Scheme
(ESIS) schemes, and the rest by Rashtriya Swasthya Bima
Yojana (RSBY) and state initiatives with different coverage
levels (Table 1). Interestingly, two states have achieved
particularly high coverage (Andhra Pradesh 87% and Tamil
Nadu 62%). Although insurance programs exist in India,
they, with a few exceptions, do not reimburse medicines.
Typically, for those people who are insured, only tertiary and
sometimes secondary inpatient care is covered with an
exception of CGHS and ESIS schemes which provide a full
coverage including reimbursement of drugs27. In case of
CGHS and ESIS reimbursement of medicines is not through
any formal mechanism: any drugs will be reimbursed at the
CGHS and ESIS approved centers based on the physician’s
justification of the need.
Pricing controls in India operate via the Drugs Prices Control
Order (DPCO)28-30. Approval and pricing of drugs are two
separate processes. DPCO classifies drugs as scheduled (e.g.
“First Schedule”) or non-scheduled and provides
requirements on how ceiling prices for scheduled drugs
should be calculated. The latest, 4th edition of National
Formulary of India was introduced in 2010 by the Indian
Pharmacopoeia Commission (IPC) and published in 2011

Table 2 Key Figures India
Total population

Over 1.2 billion

Political administration

28 states and 7 union
territories

GDP based on purchasingpower-parity per capita ($)

3,991

Life expectancy at birth m/f
(years)

67.3/69.6

Source: International Monetary Fund; Health and family welfare
statistics in India 2013.

after a gap of more than 30 years31. The NFI 2010 is an
important guide for health care professionals as it promotes
the rational use of medicines in the country. There is also a
National List of Essential Medicines (NLEM) which currently
contains 348 commonly used drugs in India32. All of these
drugs are under price control33. This list was last updated in
2011 and is based on the World Health Organization’s
(WHO) Essential Drugs List. The National Pharmaceutical
Pricing Authority (NPPA) fixes and monitors the prices of all
scheduled
drug
formulations
(both
manufactured
domestically and imported).
The prices of non-scheduled medicines (medicines that do
not fall under the price control) are simply monitored for
price increases. Prices of non-scheduled patented drugs are
set by manufacturers. However, there is a 10% ceiling on
annual price increases of non-scheduled drugs, and the
NPPA can take corrective measures (including price fixing)
for products with prices that increase by more than 10% in a
year30. Also when the government feels that the high price of
patented drug is limiting its availability, it can introduce
compulsory licensing. This, for example, was applied to
Bayer’s Nexavar (sorafenib)34.
Table 3 Indian Health care expenditure
Indicator

India

OECD
average

Health expenditure as a
share of GDP, 2011

3.9%

9.3%

Health expenditure per
capita, 2011 ($)

141

3,322

Practicing doctors per
1,000 population, 2011

0.7

3.2

Source: OECD. Health at a Glance 2013.

References:14Venkatesh KK et al. Clinical impact and cost-effectiveness of expanded voluntary HIV testing in India. PLoS One. 2013 May 31;8(5). 15Verguet S. et
al. Public finance of rotavirus vaccination in India and Ethiopia: an extended cost-effectiveness analysis. Vaccine. 2013 Oct 1;31(42):4902-10. 16Hass B et al. Health
technology assessment and its role in the future development of the Indian healthcare sector. Perspect Clin Res. 2012 Apr;3(2):66-72. 17Gupta I, Guin G.
Communicable diseases in the South-East Asia Region of the World Health Organization: towards a more effective response. Bulletin of the World Health
Organization 2010; 88: 199-205. 18Patel V et al. Chronic diseases and injuries in India. Lancet 2011; 377: 413–28. 19Ranade AA et al. Clinical and economic
implications of the use of nanoparticle paclitaxel (Nanoxel) in India. Annals of Oncology 24 (Sup 5): v6–v12, 2013. 20Aggarwal K et al. Comparison of clinical and
cost-effectiveness of psoralen + ultraviolet A versus psoralen + sunlight in the treatment of chronic plaque psoriasis in a developing economy. Int J Dermatol. 2013
Apr;52(4):478-85. 21WHO Country Cooperation Strategy Brief. India (2013). 22Industry review at a glance. Pacific Business Review International Vol 6, Issue 6, Dec
2013. 23India Pharma 2020. Propelling access and acceptance, realising true potential. McKinsey&amp;Company. 24Bose A, Mehta R. Enabling Access to Long-Term
Finance for Healthcare in India. Oct 2013. 25La Forgia G, Nagpal S. Government-Sponsored Health Insurance in India. Are You Covered? The World Bank 2012.
26
Catastrophic Payments and Impoverishment due to Out-of-Pocket Health Spending. Economic &amp; Political Weekly Vol xlvi No 47 Nov 2011. 27Reddy KS et al. A
Critical Assessment of the Existing Health Insurance Models in India. Public Health Foundation of India. January 2011. 28Price Controls on Pharmaceutical Products
in India 2007 National University of Singapore. 29Narayan S. Price controls on pharmaceutical products in India. ISAS Working Paper No. 20. Mar 2007. 30National
Pharmaceuticals Pricing Policy, 2012. The Gazette of India, 7 Dec 2012. 31Gitanjali B. The National Formulary of India 2010: Thorough and extensive revision of the
preprint version needed. J Pharmacol Pharmacother. 2011;2(4): 219–20. 32Bansal D, Purohit VK. Accessibility and use of essential medicines in health care:
Current progress and challenges in India. J Pharmacol Pharmacother 2013;4:13-8. 33Francis PA. Revision of NLEM. 2013. 34Ghangurde A. Indian govt working on
list of drugs fit for compulsory licensing? Scrip Magazine January 2013.

5

 
  </li>
  <li>
      <a href="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/95/hta-uncovered-february-2014-6-638.jpg?cb=1393564255" title="HTA U nco v e red : Is s u e N o. 4 - F e bru ar y 2 0 14

..." target="_blank">
        6.
      </a>
    HTA U nco v e red : Is s u e N o. 4 - F e bru ar y 2 0 14

HTA figures around the globe during
2012-2013
Digging into our HTA Watch database, we were able to
provide some interesting insights on the HTA activity
worldwide during the past two years. Supporting the feel
of a generalised fast-growing HTA activity in all parts of
the world with actual figures, our statistics can help get a
more precise idea on the current status and give a hint of
the future evolution.
A general increase in the number of reports published
was observed worldwide. As appreciated in Figure 1, two
of the agencies with the highest increase were NCPE in
Ireland and pCODR in Canada with an increase of 60%72% in the number of published reports in 2013 in
comparison with 2012. Both NICE and SMC incremented
their publications, while AWMSG remained stable. The
overall HTA activity by these three bodies in the United
Kingdom increased considerably (around 20%).
Nevertheless, not all agencies augmented their output.
INESSS published slightly less reports in 2013 compared
with 2012 (a notable decrease of 22%), similar to
CADTH. The overall production in Canada showed a
decrease of 14%. Similar relative decrease was observed
in the Netherlands for CVZ (around 13%). HTA activity
remained overall stable in France, Sweden, Spain (results
not shown) and Australia.

Facts and Figures
In the course of 2013, 1,659 HTA reports were completed

and published worldwide, exceeding the 1,530 reports
published during 2012.
 France’s Haute Autorité de Santé (HAS) had the highest
number of publications with 208 reports during 2013,
followed by Sweden’s Tandvårds-ochLäkemedelsförmåns Verket (TLV) with 125 reports.
NICE, Canada’s National Institute for Excellence in
Health and Social Services (INESSS), Scotland’s Scottish
Medicines Consortium (SMC) and UK’s National Horizon
Scanning Centre (NHSC) all published approximately a
hundred reports in the same time period (101, 98,




97 and 96 respectively).
However, UK’s HTA agencies together accounted for
approximately one fourth of all reports published
worldwide (411), followed by Canada (224) and

France (208). Reports from these three countries
comprise half of the evaluations published around the
globe.
As observed in all individuals quarters, cancer and

cardiovascular were the most reviewed



therapeutic areas worldwide. Among cancer studies,
breast and prostate cancer were mostly evaluated,
followed by Non Small Cell Lung Cancer (NSCLC),
colorectal cancer, renal cell carcinoma and melanoma.
Diabetes-related indications, such as
diabetes, diabetic nephropathy or macular oedema, take
the lead as the most reviewed indications worldwide
during 2013 with 133 published evaluations.

Figure 2: Reports published by selected agendies during
2012-2013
pCODR

+80%

2013

AWMSG

0%

G-BA

+12%

CONITEC

+71%

NCPE

2012

+67%

CVZ

-14%

PBAC

+5%

INESSS

-22%

NICE

+28%

SMC

+18%

TLV

-1%

CADTH

-13%

HAS

+2%

0

100
200
300
400
Number of reports published

500

In the Latin American fast-growing front, CONITEC
started its trajectory in Brazil in the end of 2011 as a
successor of CITEC and showed an increase of 71% in
published assessments in 2013 compared with 2012 (see
Figure 1), which is expected to rise even more in the
coming years. Adding to the HTA growing activity, new
bodies have made their appearance during 2013.
Colombia had its premiere with the Instituto de
Evaluación Tecnológica en Salud (IETS) in late 2013 with
more than 50 evaluations and clinical practice guidelines.
Keep an eye on our next issue for more insights on Latin
America.
Back to Europe, the Therapeutic Positioning Reports
announced as a centralised HTA evaluation process in
Spain (see also our HTA Uncovered Issue #1) made their
way to the public domain on the Spanish Drug Agency
website (AEMPS). Two reports were already published in
2012 and 5 more saw the light during 2013. The Finnish
Medicine Agency (FIMEA) has also launched HTA drug
evaluation activities and published its first report in 2011,
one more in 2012 and four in 2013.
Regarding the therapeutic areas assessed by selected
agencies (PBAC, pCODR, INESSS, CADTH, G-BA, CVZ,
NICE, SMC, AWMSG, NCPE, CONITEC, TLV), while
cardiovascular are among the mostly evaluated
indications, there was a decrease in the number of
publications in this area (25%). Central nervous system
indications also dropped considerably, while cancer
remained on the top of the list. Diabetes and digestive
system indications also showed a considerable increase
(Figure 2).
Note that not all HTA agencies have the exact same
scope. For example, some of the selected HTA agencies
publish clinical practice guidelines along with HTA
evaluations, which may increase the total number of
publications (eg. NICE, CADTH and CONITEC), whereas
others are limited to drugs (eg. SMC). Data for HAS and
PBAC showed in figure refer only to drug evaluations.
6

 
  </li>
  <li>
      <a href="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/95/hta-uncovered-february-2014-7-638.jpg?cb=1393564255" title="HTA U nco v e red : Is s u e N o. 4 - F e bru ar y 2 0 14

..." target="_blank">
        7.
      </a>
    HTA U nco v e red : Is s u e N o. 4 - F e bru ar y 2 0 14

Upcoming publications and events
 Meet us at the Pharma Pricing &amp; Market Access
Outlook Europe 2014 (London; 25-26 February 2014).
To register visit:
http://www.healthnetworkcommunications.com/conferen
ce/pharma-pricing-market-access/
 Meet us at the DIA 26th Annual EuroMeeting
(Vienna, Austria; 25-27 March 2014).
o The effect of Patient Reported Outcomes on
Health Technology Assessment recommendations
in oncology in France, Germany and UK.
 Meet us at the Pharmaccess Leader Forum, (Paris; 1921 May 2014). To register visit:
http://springpharmaccess2014.nextlevelpharma.com/
 Learn more about our HTA insights at the ISPOR 19th
Annual International meeting (Montreal, Canada; 31
May-4 June 2014).

Glossary

Next time in HTA Uncovered
HTA insights from Turkey

 The Turkish Government is midway through the
implementation
of
the
“Health
Care
Transformation Program” that was initiated in
2004. The program is intended to be the driver of
greater public access to health services and
treatments. The program coincides with findings
that innovative drugs are a key driver for
increasing life expectancy in Turkey and that the
percentage of Turkey‟s population with health
insurance is also increasing.
 A key strategic objective is the highest possible
patient access to health technologies that would
ensure that Turkish citizens benefit from
innovative therapeutics once on the market. In
order to achieve this objective robust pricing and
reimbursement procedures need to be established
in order to attract further investment from
pharmaceutical sponsors.
 Therefore with no formal Health Technology
Assessment process in place, the speed at which
new health technologies are able to gain access
to the Turkish market remains a „known unknown‟.
A Statement released from the Ministry of Health
indicates the Turkish Government‟s intent for a
national HTA unit to develop in line with
established Western European HTA agencies.
Future HTA‟s will be an evaluation of clinical
effectiveness and patient safety coupled with
economic, social and ethical aspects.
 In our next edition we will examine the proposed
status of HTA in Turkey.

ASBY

Apka Swasthya Bima Yojna

AP

Andhra Pradesh

APL

Above Poverty Line

BPL

Below Poverty Line

GDP

Gross Domestic Product

CEA

Cost-effectiveness analysis

CGHS

Central Government Health Scheme

CMA

Cost-minimization analysis

CUA

Cost-utility analysis

DPCO

Drugs Prices Control Order

DHR

Department of Health Research

ESIS

Employees‟ State Insurance Scheme

GOI

Government of India

HTA

Health Technology Assessment

HTA dissemination and current developments in
Latin America

HP

Himachal Pradesh

 Despite the socioeconomic and health provision

IPC

Indian Pharmacopoeia Commission

ISPOR

International Society For Pharmacoeconomics
and Outcomes Research

KN

Karnataka

NFI

National Formulary of India

NICE

National Institute for Health and Care Excellence

NLEM

National List of Essential Medicines

NPPA

National Pharmaceutical Pricing Authority

OECD

Organisation for Economic Co-operation and
Development

PEG-I

Proposed Pharmacoeconomics Guidelines for
India

RSBY

Rashtriya Swasthya Bima Yojana

SQA

Structured Quick Assessment

differences in the countries of Latin America, there
is a common effort towards improved allocation of
resources and global health coverage.
 HTA initiatives have been present since at least
1985 in some of the countries, but did not
necessarily assess economic aspects. These
have started to get incorporated in the past
decade and have resulted in Networks of
Collaboration, such as the Andean Network of
HTA or the Network of HTA (RedETSA), the latter
including members of both Andean and Mercosur
economic groups.
 The next issue of HTA Uncovered will examine
the current landscape and efforts in the region and
discuss the challenges to be overcome.

TN

Tamil Nadu

WHO

World Health Organization
7

 
  </li>
  <li>
      <a href="http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/95/hta-uncovered-february-2014-8-638.jpg?cb=1393564255" title="HTA U nco v e red : Is s u e N o. 4 - F e bru ar y 2 0 14

..." target="_blank">
        8.
      </a>
    HTA U nco v e red : Is s u e N o. 4 - F e bru ar y 2 0 14

More information about
Quintiles’ HTA Solutions
HTA Watch
Quintiles‟ HTA Watch is a web-based service offering instant access to a global repository of published HTA
reports from nearly 100 agencies in 32 countries, providing regularly updated assessments to inform life sciences
and healthcare companies‟ strategic decision-making. Our industry and regional experts track and monitor this
vast network of global agencies, providing summaries that include key clinical and economic outcomes, agency
comments, and final recommendations. Direct web links to the full report detail are available, minimizing the need
to navigate multiple agency websites.

Please contact us if you would like to receive a demonstration.

Contact us
Quintiles Consulting
Toll free: +1 866 267 4479
Direct telephone: +1 973 850 7571
International: +31 23 567 0991
On the web: www.quintiles.com/consulting
Email: consulting@quintiles.com

Anke van Engen
Office: + 31 (0) 23 5670990
Mobile: + 31 (0) 6 46236510
anke.vanengen@quintiles.com
Lars Heemstra
Office: + 31 (0) 23 5671013
Mobile: + 31 (0) 6 46436563
lars.heemstra@quintiles.com

HTA factsheet
Available from
http://www.quintiles.com/hta-watch

8
Copyright © 2014 Quintiles. 14.30.04-022014

*Any assessments or evaluations are provided by Quintiles as a service for
information purposes only, and are based on the HTA reports referenced above.

 
  </li>

              </ol>
            </div>
      </div>
    </div>

    <aside id="side-panel" class="small-12 large-4 columns j-related-more-tab">
      
<dl class="tabs related-tabs small" data-tab>
    <dd class="active">
      <a href="#related-tab-content" data-ga-cat="bigfoot_slideview" data-ga-action="relatedslideshows_tab">
        Recommended
      </a>
    </dd>
</dl>

<div class="tabs-content">
    <ul id="related-tab-content" class="content active no-bullet notranslate">

        <li class="j-related-item">
  <a data-ssid="5874557"
    data-algo-id="21"
    data-source-name="BROWSEMAP"
    data-source-model="21"
    data-urn-type="Slideshow"
    data-score="1"
    class="j-related-impression slideview_related_item j-recommendation-tracking"
    title="A Shortcut to Medical Device Reimbursement in Germany"
    href="/Mediclever/a-shortcut-to-medical-device-reimbursement-in-germany">

    <div class="related-thumbnail">
      <img class="j-thumbnail j-lazy-thumb"
        alt="A Shortcut to Medical Device Reimbursement in Germany"
        src="//public.slidesharecdn.com/b/images/thumbnail.png"
        data-original="//cdn.slidesharecdn.com/ss_thumbnails/5-101123080940-phpapp01-thumbnail-2.jpg?cb=1422631231" />
    </div>

    <div class="related-content">
      <div class="title">
        A Shortcut to Medical Device Reimbursement in Germany
      </div>

        <div class="author">Amir Inbar</div>

    </div>
  </a>
</li>

        <li class="j-related-item">
  <a data-ssid="11737475"
    data-algo-id="21"
    data-source-name="BROWSEMAP"
    data-source-model="21"
    data-urn-type="Slideshow"
    data-score="1"
    class="j-related-impression slideview_related_item j-recommendation-tracking"
    title="Who"
    href="/Clapbio/who-11737475">

    <div class="related-thumbnail">
      <img class="j-thumbnail j-lazy-thumb"
        alt="Who"
        src="//public.slidesharecdn.com/b/images/thumbnail.png"
        data-original="//cdn.slidesharecdn.com/ss_thumbnails/who-120224124103-phpapp02-thumbnail-2.jpg?cb=1330087946" />
    </div>

    <div class="related-content">
      <div class="title">
        Who
      </div>

        <div class="author">Clapbio</div>

    </div>
  </a>
</li>

        <li class="j-related-item">
  <a data-ssid="10690799"
    data-algo-id="21"
    data-source-name="BROWSEMAP"
    data-source-model="21"
    data-urn-type="Slideshow"
    data-score="1"
    class="j-related-impression slideview_related_item j-recommendation-tracking"
    title="Drugs"
    href="/roh46/drugs-10690799">

    <div class="related-thumbnail">
      <img class="j-thumbnail j-lazy-thumb"
        alt="Drugs"
        src="//public.slidesharecdn.com/b/images/thumbnail.png"
        data-original="//cdn.slidesharecdn.com/ss_thumbnails/drugs-111226083857-phpapp02-thumbnail-2.jpg?cb=1324888798" />
    </div>

    <div class="related-content">
      <div class="title">
        Drugs
      </div>

        <div class="author">roh46</div>

    </div>
  </a>
</li>

        <li class="j-related-item">
  <a data-ssid="640689"
    data-algo-id="21"
    data-source-name="BROWSEMAP"
    data-source-model="21"
    data-urn-type="Slideshow"
    data-score="1"
    class="j-related-impression slideview_related_item j-recommendation-tracking"
    title="Rethink the Academic Talk - 2"
    href="/m_gemmill_toyama/revived-academic-talks-2-presentation">

    <div class="related-thumbnail">
      <img class="j-thumbnail j-lazy-thumb"
        alt="Rethink the Academic Talk - 2"
        src="//public.slidesharecdn.com/b/images/thumbnail.png"
        data-original="//cdn.slidesharecdn.com/ss_thumbnails/revived-academic-talks-2-1223369431796882-9-thumbnail-2.jpg?cb=1224295777" />
    </div>

    <div class="related-content">
      <div class="title">
        Rethink the Academic Talk - 2
      </div>

        <div class="author">Marin Gemmill-Toyama</div>

    </div>
  </a>
</li>

        <li class="j-related-item">
  <a data-ssid="23856996"
    data-algo-id="21"
    data-source-name="BROWSEMAP"
    data-source-model="21"
    data-urn-type="Slideshow"
    data-score="1"
    class="j-related-impression slideview_related_item j-recommendation-tracking"
    title="Defining Innovation in Medicines: How to Transform Innovation into Value"
    href="/OHENews/defining-innovation-jm-f-june-2013">

    <div class="related-thumbnail">
      <img class="j-thumbnail j-lazy-thumb"
        alt="Defining Innovation in Medicines: How to Transform Innovation into Value"
        src="//public.slidesharecdn.com/b/images/thumbnail.png"
        data-original="//cdn.slidesharecdn.com/ss_thumbnails/defininginnovationjm-fjune2013-130703085957-phpapp01-thumbnail-2.jpg?cb=1372845809" />
    </div>

    <div class="related-content">
      <div class="title">
        Defining Innovation in Medicines: How to Transform Innovation into Value
      </div>

        <div class="author">Office of Health Economics</div>

    </div>
  </a>
</li>

        <li class="j-related-item">
  <a data-ssid="39797605"
    data-algo-id="21"
    data-source-name="BROWSEMAP"
    data-source-model="21"
    data-urn-type="Slideshow"
    data-score="1"
    class="j-related-impression slideview_related_item j-recommendation-tracking"
    title="Managed Entry Agreements in Asia "
    href="/OHENews/high-priced-drugs-issues-panel-ispor-beijing-towse-2014">

    <div class="related-thumbnail">
      <img class="j-thumbnail j-lazy-thumb"
        alt="Managed Entry Agreements in Asia "
        src="//public.slidesharecdn.com/b/images/thumbnail.png"
        data-original="//cdn.slidesharecdn.com/ss_thumbnails/highpriceddrugsissuespanelisporbeijingtowse2014-141002081955-phpapp01-thumbnail-2.jpg?cb=1412247457" />
    </div>

    <div class="related-content">
      <div class="title">
        Managed Entry Agreements in Asia 
      </div>

        <div class="author">Office of Health Economics</div>

    </div>
  </a>
</li>

        <li class="j-related-item">
  <a data-ssid="27921881"
    data-algo-id="21"
    data-source-name="BROWSEMAP"
    data-source-model="21"
    data-urn-type="Slideshow"
    data-score="1"
    class="j-related-impression slideview_related_item j-recommendation-tracking"
    title="Q3 a r2_ step4"
    href="/pharmaguideline/q3-a-r2-step4">

    <div class="related-thumbnail">
      <img class="j-thumbnail j-lazy-thumb"
        alt="Q3 a r2_ step4"
        src="//public.slidesharecdn.com/b/images/thumbnail.png"
        data-original="//cdn.slidesharecdn.com/ss_thumbnails/q3ar2step4-131105062102-phpapp01-thumbnail-2.jpg?cb=1383632712" />
    </div>

    <div class="related-content">
      <div class="title">
        Q3 a r2_ step4
      </div>

        <div class="author">Pharmaguideline</div>

    </div>
  </a>
</li>

        <li class="j-related-item">
  <a data-ssid="8469507"
    data-algo-id="21"
    data-source-name="BROWSEMAP"
    data-source-model="21"
    data-urn-type="Slideshow"
    data-score="1"
    class="j-related-impression slideview_related_item j-recommendation-tracking"
    title="AMNOG - Germany&#x27;s Healthcare Reform and The impact on Global Pharmaceutical Market Access Strategies"
    href="/IHS/amnog-the-impact-of-germanys-healthcare-reform-on-global-pharmaceutical-market-access-strategies">

    <div class="related-thumbnail">
      <img class="j-thumbnail j-lazy-thumb"
        alt="AMNOG - Germany&#x27;s Healthcare Reform and The impact on Global Pharmaceutical Market Access Strategies"
        src="//public.slidesharecdn.com/b/images/thumbnail.png"
        data-original="//cdn.slidesharecdn.com/ss_thumbnails/amnog-impact-on-global-pharmaceutical-market-access-strategies-110630092441-phpapp01-thumbnail-2.jpg?cb=1351594950" />
    </div>

    <div class="related-content">
      <div class="title">
        AMNOG - Germany&#x27;s Healthcare Reform and The impact on Global Pharmaceutical M...
      </div>

        <div class="author">IHS </div>

    </div>
  </a>
</li>

        <li class="j-related-item">
  <a data-ssid="63249775"
    data-algo-id=""
    data-source-name="MORE_FROM_USER"
    data-source-model=""
    data-urn-type="Slideshow"
    data-score=""
    class="j-related-impression slideview_related_item j-recommendation-tracking"
    title="Krupanandhi college magazine 20th may 2016"
    href="/harshadoddihal/krupanandhi-college-magazine-20th-may-2016">

    <div class="related-thumbnail">
      <img class="j-thumbnail j-lazy-thumb"
        alt="Krupanandhi college magazine 20th may 2016"
        src="//public.slidesharecdn.com/b/images/thumbnail.png"
        data-original="//cdn.slidesharecdn.com/ss_thumbnails/krupanandhicollegemagazine20thmay2016-160620132652-thumbnail-2.jpg?cb=1466429251" />
    </div>

    <div class="related-content">
      <div class="title">
        Krupanandhi college magazine 20th may 2016
      </div>

        <div class="author">Dr.Harsha Doddihal</div>

    </div>
  </a>
</li>

        <li class="j-related-item">
  <a data-ssid="42033512"
    data-algo-id=""
    data-source-name="MORE_FROM_USER"
    data-source-model=""
    data-urn-type="Slideshow"
    data-score=""
    class="j-related-impression slideview_related_item j-recommendation-tracking"
    title="Trends &amp; Developments in Healthcare "
    href="/harshadoddihal/trends-developments-in-healthcare">

    <div class="related-thumbnail">
      <img class="j-thumbnail j-lazy-thumb"
        alt="Trends &amp; Developments in Healthcare "
        src="//public.slidesharecdn.com/b/images/thumbnail.png"
        data-original="//cdn.slidesharecdn.com/ss_thumbnails/trendsdevelopmentsinhealthcare-141126012039-conversion-gate02-thumbnail-2.jpg?cb=1416965136" />
    </div>

    <div class="related-content">
      <div class="title">
        Trends &amp; Developments in Healthcare 
      </div>

        <div class="author">Dr.Harsha Doddihal</div>

    </div>
  </a>
</li>

    </ul>

</div>

    </aside>
  </div>
</div>





      

      

        <footer>
            <div class="row">
              <div class="columns">
                <div id="smt-lang-selector"></div>
                <ul class="j-languages-selector language-links text-center">
                  <li class="smt-item j-www">
                    <a class="smt-link"
                      href="http://www.slideshare.net/harshadoddihal/hta-uncovered-february-2014-31757069?smtNoRedir=1"
                      title="HTA Uncovered february 2014 - English" lang="en" hreflang="en">English
                    </a>
                  </li>
                  <li class="smt-item j-es">
                    <a class="smt-link"
                      href="http://es.slideshare.net/harshadoddihal/hta-uncovered-february-2014-31757069"
                      title="HTA Uncovered february 2014 - Espanol" lang="es" hreflang="es">Espa&#xF1;ol
                    </a>
                  </li>
                  <li class="smt-item j-pt">
                    <a class="smt-link"
                      href="http://pt.slideshare.net/harshadoddihal/hta-uncovered-february-2014-31757069"
                      title="HTA Uncovered february 2014 - Portugues" lang="pt" hreflang="pt">Portugu&#xEA;s
                    </a>
                  </li>
                  <li class="smt-item j-fr">
                    <a class="smt-link"
                      href="http://fr.slideshare.net/harshadoddihal/hta-uncovered-february-2014-31757069"
                      title="HTA Uncovered february 2014 - Fran&ccedil;ais" lang="fr" hreflang="fr">Fran&ccedil;ais
                    </a>
                  </li>
                  <li class="smt-item j-de">
                    <a class="smt-link"
                      href="http://de.slideshare.net/harshadoddihal/hta-uncovered-february-2014-31757069"
                      title="HTA Uncovered february 2014 - Deutsche" lang="de" hreflang="de">Deutsch
                    </a>
                  </li>
                </ul>
              </div>
            </div>

          <div class="row">
            <div class="columns">
              <ul class="main-links text-center">
                <li><a href="/about">About</a></li>
                <li class="hidden-for-small"><a href="/developers">Dev & API</a></li>
                <li><a href="http://blog.slideshare.net/">Blog</a></li>
                <li><a href="/terms">Terms</a></li>
                <li><a href="/privacy">Privacy</a></li>
                <li><a href="http://www.linkedin.com/legal/copyright-policy">Copyright</a></li>
                <li class="hidden-for-small"><a href="https://www.linkedin.com/help/slideshare">Support</a></li>
              </ul>
            </div>
          </div>

          <div class="row">
            <div class="columns">
              <ul class="social-links text-center">
                <li>
                  <a title="Follow us on LinkedIn" href="http://www.linkedin.com/company/linkedin" class="fa fa-linkedin-square fa-lg" rel="nofollow" target="_blank"></a>
                </li>
                <li>
                  <a title="Follow us on Facebook" href="http://www.facebook.com/slideshare" class="fa fa-facebook-square fa-lg" rel="nofollow" target="_blank"></a>
                </li>
                <li>
                  <a title="Follow us on Twitter" href="http://twitter.com/SlideShare" class="fa fa-twitter-square fa-lg" rel="nofollow" target="_blank"></a>
                </li>
                <li>
                  <a title="Follow us on Google+" href="http://www.google.com/+LinkedIn" class="fa fa-google-plus-square fa-lg" rel="nofollow" target="_blank"></a>
                </li>
                <li>
                  <a href="http://www.slideshare.net/rss/latest" class="fa fa-rss-square fa-lg"></a>
                </li>
              </ul>
            </div>
          </div>

          <div class="row">
            <div class="columns">
              <p class="copyright text-center">LinkedIn Corporation &copy; 2016</p>
              <p></p>
            </div>
          </div>
        </footer>
    </div>

    <div id="alert-modal" class="reveal-modal" data-reveal="">
      <p></p>
      <a class="close-reveal-modal">×</a>
    </div>

    <div class="modal_popup_container">
          
<div id="clipboard-share-modal" class="reveal-modal small mobile-hide" aria-hidden="true" aria-labelledby="modal-title" role="dialog" data-reveal data-ga-track-category="" data-ga-track-action="" translate="no">
  <div class="j-modal-popup modal-popup">
    <div id="modal-content" class="j-modal-content">
      <h4 class="j-modal-title modal-title notranslate">Share Clipboard</h4>
      <hr />
      <a class="close-reveal-modal" href="#" aria-label="Close">&times;</a>
      <div class="section share-email">
        <form class="j-share-email-form">
          <h5>Email</h5>
          <input class="j-share-email-to j-email-clear notranslate" name="recipients" placeholder="Enter email addresses" title="Enter email addresses" type="text">
          <div class="clearfix">
            <input data-ga="name" class="j-share-email-name j-email-clear notranslate" name="name" type="text" placeholder="From" title="From">
            <textarea class="j-share-email-msg j-email-clear notranslate share-message-textarea" name="message" placeholder="Add a message" title="Add a message"></textarea>
            <div class="j-email-flash email-flash"></div>
            <input id="share-email-send"class="button btn btn-inverse email-send-button notranslate" title="Send" type="submit" value="Send">
          </div>
        </form>
        <div id="email-sent" class="j-email-sent sent-section">
          <span class="success-text notranslate">Email sent successfully..</span>
        </div>
      </div>
      <div class="row">
        <ul class="j-share-social-list share-social-list" data-canonical-url="">
          <li class="facebook" data-network="facebook">
            <a class="share-link"
              rel="nofollow"
              title="Share on Facebook">Facebook</a>
          </li>
          <li class="twitter" data-network="twitter">
            <a class="share-link"
              rel="nofollow"
              title="Tweet on Twitter">Twitter</a>
          </li>
          <li class="linkedin" data-network="linkedin">
            <a class="share-link"
              rel="nofollow"
              title="Share on LinkedIn">LinkedIn</a>
          </li>
          <li class="googleplus" data-network="googleplus">
            <div class="social-hover">
              <a class="share-link"
                rel="nofollow"
                title="Share on Google+">Google+</a>
            </div>
          </li>
        </ul>
      </div>
      <div class="row">
        <div class="share-link-container">
          <label for="share-link-url">Link</label>
          <input id="share-link-url" class="j-share-link-url" type="text" data-ga="link"></input>
        </div>
      </div>
    </div>
  </div>
</div>

    <div id="top-clipboards-modal"
     class="reveal-modal xlarge top-clipboards-modal"
     data-reveal
     aria-labelledby="modal-title"
     aria-hidden="true"
     role="dialog">
  <h4 class="modal-title">Public clipboards featuring this slide</h4>
  <hr />
  <button class="close-reveal-modal button-lrg" aria-label="Close">&times;</button>
  <div class="loading text-center">
    <svg><use data-size="small" xlink:href="#loader"></use></svg>
  </div>
  <div class="empty">
    No public clipboards found for this slide
  </div>

  <div class="clipboards row">
    <ul class="small-block-grid-1 medium-block-grid-2 large-block-grid-3"></ul>
  </div>
</div>

    
<div id="download-interstitial-modal" class="download-interstitial reveal-modal medium" aria-hidden="false" role="dialog" data-reveal>
  <div class="modal-content-container">
    <a class="close-reveal-modal" href="#" aria-label="Close">&times;</a>
    <div class="modal-content">
      <div class="modal-inner-content">
        <div class="row">
          <h3 class="text-center">Save the most important slides with Clipping</h3>
        </div>
        <div class="row">
          <!-- make only 8/12 columns and centered -->
          <div class="medium-10 small-centered columns">
            <p class="text-center">Clipping is a handy way to collect and organize the most important slides from a presentation. You can keep your great finds in clipboards organized around topics.</p>
            <button class="art-deco small primary start-clipping">Start clipping</button>
            <button class="art-deco small tertiary button continue-download" data-reveal-id="login_modal" href="/login?from_source=%2Fharshadoddihal%2Fhta-uncovered-february-2014-31757069%3Ffrom_action%3Dsave&amp;from=download&amp;layout=foundation">No thanks. Continue to download.</button>
          </div>
        </div>
      </div>
    </div>
  </div>
</div>

    <div id="select-clipboard-modal" class="reveal-modal medium" data-reveal aria-labelledby="modal-title" aria-hidden="true" role="dialog" translate="no">
  <div class="modal-header-container">
    <h4 class="modal-title">Select another clipboard</h4>
    <hr />
    <a class="close-reveal-modal button-lrg" href="#" aria-label="Close">&times;</a>
  </div>

  <div class="loading">
    <svg><use data-size="small" xlink:href="#loader"></use></svg>
  </div>

  <div class="modal-content">

    <div class="default-clipboard-panel radius">
      <p>Looks like you’ve clipped this slide to <strong class="default-clipboard-title"></strong> already.</p>
    </div>

    <div class="clipboard-search-input-container">
      <i class="fa fa-search"></i>
      <input class="clipboard-search-input" type="text" placeholder="Search for a clipboard">
    </div>

    <div class="clipboard-list-container">
      <ul class="existing-clipboard-list"></ul>
      <ul class="clipboard-list"></ul>
      <div class="clipboard-create-new">
        <div class="clipboard-item-thumb">
          <i class="fa fa-plus"></i>
        </div>
        <div class="clipboard-item-title">Create a clipboard</div>
      </div>
    </div>
  </div>
</div>

    <div id="clipboard-create-modal" class="reveal-modal medium" data-reveal aria-labelledby="modal-title" aria-hidden="true" role="dialog" translate="no">
    <div class="first-clip-message hide">
      <h3>You just clipped your first slide!</h3>
      <span>
        Clipping is a handy way to collect important slides you want to go back to later. Now customize the name of a clipboard to store your clips.
      </span>
    </div>
    <h4 class="modal-title"></h4>
    <hr />
    <form data-abide>
    <div class="row">
      <div class="j-title-wrapper input-wrapper notranslate">
        <label>Name*
          <input type="text" class="j-title-input" placeholder="Best of Slides"/>
          <small class="j-title-error error hide"></small>
        </label>
      </div>
    </div>

    <div class="row">
      <div class="j-description-wrapper input-wrapper notranslate">
        <label>Description
          <input type="text" class="j-description-input" placeholder="Add a brief description so others know what your Clipboard is about."/>
          <small class="j-description-error error hide"></small>
        </label>
      </div>
    </div>

    <div class="row">
      <label>Visibility
        <div class="switch small notranslate">
          <small id="privacy-switch-description">Others can see my Clipboard</small>
          <input id="privacy-switch" class="j-privacy-input" type="checkbox" />
          <label for="privacy-switch"></label>
        </div>
      </label>
    </div>

        <div class="row">
          <div class="pull-right">
            <button class="j-cancel-button button-ghost small notranslate" type="button">Cancel</button>
            <button class="j-submit-button button-linkedin small notranslate" type="submit">Save</button>
          </div>
        </div>
    </form>
    <input type="hidden" class="j-i18n-edit-clipboard-modal" value='{&quot;privacyEnabled&quot;:&quot;Clipboard is visible only to me.&quot;,&quot;formTitleCreate&quot;:&quot;Create a clipboard&quot;,&quot;privacyDisabled&quot;:&quot;Others can see my Clipboard&quot;,&quot;formTitleEdit&quot;:&quot;Edit Clipboard&quot;}'
    />

</div>


    </div>

    <script src="http://public.slidesharecdn.com/b/ss_foundation/combined_foundation_base.js?ebdceaad14" type="text/javascript"></script>

    <script>
      $(window).load(function() {
        loadCSS("//public.slidesharecdn.com/b/ss_foundation/stylesheets/app.css?98ac6f25d9ed7cf0629ed09dc3b07e08935c699e");
      });
    </script>

    
  <script type="text/javascript">
    $.extend(true, slideshare_object, {"presentationId":31757069,"slideshow":{"is_clickgen_enabled":false,"type":"document","is_author_premium":false,"iframe_url":"https://www.slideshare.net/slideshow/embed_code/key/A18dV3hfktsQNl","user_login":"harshadoddihal","pin_image_url":"http://cdn.slidesharecdn.com/ss_thumbnails/htauncoveredfebruary2014-140228051012-phpapp02-thumbnail-4.jpg?cb=1393564255","view_action_state":"unpublished","clickgen_url":null,"lead_form_url":"https://www.slideshare.net/slideshow/A18dV3hfktsQNl/lead-form?locale=en","recommendations":{"designKey":"design_001","finalRankerModel":"model_001"},"ss_url":"http://www.slideshare.net/harshadoddihal/hta-uncovered-february-2014-31757069","iframe_code":"\u003Ciframe src=\"{iframe_url}\" width=\"{width}\" height=\"{height}\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" style=\"border:1px solid #CCC; border-width:1px; margin-bottom:5px; max-width: 100%;\" allowfullscreen\u003E \u003C/iframe\u003E \u003Cdiv style=\"margin-bottom:5px\"\u003E \u003Cstrong\u003E \u003Ca href=\"https://www.slideshare.net/harshadoddihal/hta-uncovered-february-2014-31757069\" title=\"HTA Uncovered february 2014\" target=\"_blank\"\u003EHTA Uncovered february 2014\u003C/a\u003E \u003C/strong\u003E from \u003Cstrong\u003E\u003Ca target=\"_blank\" href=\"http://www.slideshare.net/harshadoddihal\"\u003EDr.Harsha Doddihal\u003C/a\u003E\u003C/strong\u003E \u003C/div\u003E","fullscreen_bg_color":"Black","title":"HTA Uncovered february 2014","clips":{},"id":"31757069","allow_clips":true,"total_slides":8,"allow_embeds":true,"embed_sizes":{"presets":{"preset4":{"displaySize":{"height":77,"width":70},"size":{"height":714,"width":668}},"preset1":{"displaySize":{"height":44,"width":40},"size":{"height":408,"width":382}},"preset2":{"displaySize":{"height":55,"width":50},"size":{"height":510,"width":477}},"preset3":{"displaySize":{"height":66,"width":60},"size":{"height":612,"width":572}}},"config":{"defaultPreset":"preset4"}},"social_urls":{"linkedin":"https://www.linkedin.com/cws/share?url=http%3A%2F%2Fwww.slideshare.net%2Fharshadoddihal%2Fhta-uncovered-february-2014-31757069\u0026trk=SLIDESHARE","google":"https://plus.google.com/share?url=http%3A%2F%2Fwww.slideshare.net%2Fharshadoddihal%2Fhta-uncovered-february-2014-31757069","twitter":"https://twitter.com/intent/tweet?via=SlideShare\u0026text=HTA+Uncovered+february+2014+by+%40Harshadod+http%3A%2F%2Fwww.slideshare.net%2Fharshadoddihal%2Fhta-uncovered-february-2014-31757069","facebook":"https://facebook.com/sharer.php?u=http%3A%2F%2Fwww.slideshare.net%2Fharshadoddihal%2Fhta-uncovered-february-2014-31757069\u0026t=HTA+Uncovered+february+2014"},"clip_counts":{},"is_private":false,"wp_code":"[slideshare id=31757069\u0026doc=htauncoveredfebruary2014-140228051012-phpapp02\u0026type=d]","zeroclipboard_url":"http://static.slidesharecdn.com/ZeroClipboardv2.swf","is_clippable":false,"facade_slide_url":"http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/95/hta-uncovered-february-2014-1-638.jpg?cb=1393564255","user_name":"Dr.Harsha Doddihal"},"embeds_count":2,"key":false,"facebook_app_id":"2490221586","stripped_title":"hta-uncovered-february-2014-31757069","analytics_api_enabled":true,"comments":{"total_count":0,"ajaxurl":"/~/slideshow/comments/31757069.json","captcha_url":"http://s3.amazonaws.com/ss-captchas/"},"jsplayer":{"spinner_url":"//public.slidesharecdn.com/b/images/ssplayer/loading_bigfoot.gif?8d8fb5905f","bucket_location":"//html.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/","iframe_url":"//www.slideshare.net/slideshow/embed_code/key/A18dV3hfktsQNl","spinner_url_fullscreen":"//public.slidesharecdn.com/b/images/ssplayer/loading_black.gif?468e48bc3a","pin_image_url":"http://image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02/95/hta-uncovered-february-2014-1-638.jpg?cb=1393564255","is_only_private":false,"next_prev_experiment":true,"show_related_content":"1","player_bgcolor":"jsplBgColorBigfoot","stripped_title":"hta-uncovered-february-2014-31757069","lastscreen":{"url":"http://www.slideshare.net/harshadoddihal/hta-uncovered-february-2014-31757069","related":[{"thumbnail":"//cdn.slidesharecdn.com/ss_thumbnails/5-101123080940-phpapp01-thumbnail.jpg?cb=1422631231","url":"/Mediclever/a-shortcut-to-medical-device-reimbursement-in-germany","author":"Amir Inbar","title":"A Shortcut to Medical Device Reimbu...","author_login":"Mediclever","views":2141},{"thumbnail":"//cdn.slidesharecdn.com/ss_thumbnails/who-120224124103-phpapp02-thumbnail.jpg?cb=1330087946","url":"/Clapbio/who-11737475","author":"Clapbio","title":"Who","author_login":"Clapbio","views":722},{"thumbnail":"//cdn.slidesharecdn.com/ss_thumbnails/drugs-111226083857-phpapp02-thumbnail.jpg?cb=1324888798","url":"/roh46/drugs-10690799","author":"roh46","title":"Drugs","author_login":"roh46","views":246},{"thumbnail":"//cdn.slidesharecdn.com/ss_thumbnails/revived-academic-talks-2-1223369431796882-9-thumbnail.jpg?cb=1224295777","url":"/m_gemmill_toyama/revived-academic-talks-2-presentation","author":"Marin Gemmill-Toyama","title":"Rethink the Academic Talk - 2","author_login":"m_gemmill_toyama","views":1211},{"thumbnail":"//cdn.slidesharecdn.com/ss_thumbnails/defininginnovationjm-fjune2013-130703085957-phpapp01-thumbnail.jpg?cb=1372845809","url":"/OHENews/defining-innovation-jm-f-june-2013","author":"Office of Health ...","title":"Defining Innovation in Medicines: H...","author_login":"OHENews","views":2645},{"thumbnail":"//cdn.slidesharecdn.com/ss_thumbnails/highpriceddrugsissuespanelisporbeijingtowse2014-141002081955-phpapp01-thumbnail.jpg?cb=1412247457","url":"/OHENews/high-priced-drugs-issues-panel-ispor-beijing-towse-2014","author":"Office of Health ...","title":"Managed Entry Agreements in Asia ","author_login":"OHENews","views":1950}]},"slideview_url":"/harshadoddihal/hta-uncovered-february-2014-31757069","timestamp":1393564255,"ppt_location":"htauncoveredfebruary2014-140228051012-phpapp02","image_ready":true,"twitter_recommended_users":"@Harshadod","toolbar_html":"\n\u003C!-- using div.bar-[top, bottom]-margin to fix toolbar spacing with a taller progressbar (improve slide scrubbing UX) --\u003E\n\u003Cdiv class=\"j-progress-bar progress-bar-wrapper\"\u003E\n  \u003Cdiv class=\"progress-bar-spacing\"\u003E\u003C/div\u003E\n  \u003Cdiv class=\"buffered-bar\"\u003E\u003C/div\u003E\n  \u003Cdiv class=\"j-slides-loaded-bar progress-bar\"\u003E\u003C/div\u003E\n  \u003Cdiv class=\"j-progress-tooltip progress-tooltip\" style=\"display: none;\"\u003E\n    \u003Cdiv class=\"j-tooltip-content progress-tooltip-wrapper\"\u003E\n      \u003Cimg class=\"j-tooltip-thumb tooltip-thumb\" onerror=\"this.src=''\"\n      \u003E\n      \u003Cspan class=\"j-slidecount-label slidecount-label\"\u003E1\u003C/span\u003E\n    \u003C/div\u003E\n    \u003Cdiv class=\"progress-tooltip-caret\"\u003E\u003C/div\u003E\n  \u003C/div\u003E\n\u003C/div\u003E\n\u003Cdiv class=\"progress-bar-spacing\"\u003E\u003C/div\u003E\n\n\n\n\u003Cdiv class=\"j-tools bot-actions\"\u003E\n\u003C/div\u003E\u003C!-- .bot-actions --\u003E\n\n\n  \u003Cdiv class=\"j-tools bot-actions\"\u003E\n    \u003Ca data-tooltip\n      aria-haspopup=\"true\"\n      style=\"display: none\"\n      class=\"j-tooltip j-download action-download has-tip\"\n      title=\"Save this \"\n      href=\"/login?from_source=%2Fharshadoddihal%2Fhta-uncovered-february-2014-31757069%3Ffrom_action%3Dsave\u0026amp;from=download\u0026amp;layout=foundation\"\n      data-target=\"#login_modal\"\n      data-placement=\"top\"\u003E\n      \u003Ci class=\"fa fa-download fa-lg\" style=\"margin-top: 1px;\"\u003E\u003C/i\u003E\n    \u003C/a\u003E\n  \u003C/div\u003E\n\n\n\n\n  \u003Cdiv class=\"nav\"\u003E\n      \u003Cbutton id=\"btnPrevious\" title=\"Previous Slide\"\u003E\n        \u003Cdiv class=\"j-prev-btn arrow-left disabled\"\u003E\u003C/div\u003E\n      \u003C/button\u003E\n    \u003Clabel class=\"goToSlideLabel\"\u003E\n      \u003Cspan id=\"current-slide\" class=\"j-current-slide\"\u003E1\u003C/span\u003E of \u003Cspan id=\"total-slides\" class=\"j-total-slides\"\u003E8\u003C/span\u003E\n    \u003C/label\u003E\n      \u003Cbutton id=\"btnNext\" title=\"Next Slide\"\u003E\n        \u003Cdiv class=\"j-next-btn arrow-right\"\u003E\u003C/div\u003E\n      \u003C/button\u003E\n  \u003C/div\u003E\n\n\n\n\u003Cdiv class=\"navActions\"\u003E\n\n    \u003Cdiv class=\"docActions\"\u003E\n      \u003Cbutton id=\"btnZoomIn\" class=\"j-tooltip btnZoomIn\" title=\"Zoom In\"\u003E\n        \u003Ci class=\"fa fa-plus fa-lg\"\u003E\u003C/i\u003E\n      \u003C/button\u003E\n      \u003Cbutton id=\"btnZoomOut\" class=\"j-tooltip btnZoomOut\" title=\"Zoom Out\"\u003E\n        \u003Ci class=\"fa fa-minus fa-lg\"\u003E\u003C/i\u003E\n      \u003C/button\u003E\n    \u003C/div\u003E\n\n\n    \u003Cbutton id=\"btnFullScreen\" class=\"j-tooltip btnFullScreen\" title=\"View Fullscreen\"\u003E\n      \u003Cspan class=\"fa fa-stack\"\u003E\n        \u003Ci class=\"fa fa-expand fa-stack-1x\"\u003E\u003C/i\u003E\n      \u003C/span\u003E\n    \u003C/button\u003E\n    \u003Cbutton id=\"btnLeaveFullScreen\" class=\"j-tooltip btnLeaveFullScreen\" title=\"Exit Fullscreen\"\u003E\n      \u003Cspan class=\"fa-stack\"\u003E\n        \u003Ci class=\"fa fa-compress fa-stack-1x\"\u003E\u003C/i\u003E\n      \u003C/span\u003E\n    \u003C/button\u003E\n\n\u003C/div\u003E\n\n","inpage_full_screen":true,"share_text":"HTA Uncovered february 2014 by Dr.Harsha Doddihal via slideshare","iframe_code":"\u003Ciframe src=\"{iframe_url}\" width=\"{width}\" height=\"{height}\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" style=\"border:1px solid #CCC; border-width:1px; margin-bottom:5px; max-width: 100%;\" allowfullscreen\u003E \u003C/iframe\u003E \u003Cdiv style=\"margin-bottom:5px\"\u003E \u003Cstrong\u003E \u003Ca href=\"https://www.slideshare.net/harshadoddihal/hta-uncovered-february-2014-31757069\" title=\"HTA Uncovered february 2014\" target=\"_blank\"\u003EHTA Uncovered february 2014\u003C/a\u003E \u003C/strong\u003E from \u003Cstrong\u003E\u003Ca target=\"_blank\" href=\"http://www.slideshare.net/harshadoddihal\"\u003EDr.Harsha Doddihal\u003C/a\u003E\u003C/strong\u003E \u003C/div\u003E","disable_eagerload":true,"show_image_player":true,"disable_lastscreen":false,"video_slides_count":0,"bambooleaf_presentation":false,"preload_after_pageload":true,"hosted_in":"slideview","start_slide":1,"bambooleaf_enabled":null,"use_ssl":false,"id":31757069,"disable_share":false,"player_type":"document","render_links":"default","bambooleaf_hash":false,"related_position":0,"sharescreen":{"slideshow_id":31757069,"title":"HTA Uncovered february 2014","url":"http://www.slideshare.net/harshadoddihal/hta-uncovered-february-2014-31757069","html":"\u003Cdiv class=\"shareScreen\"\u003E\n  \u003Ca href=\"#\" class=\"close\"\u003E\u0026times;\u003C/a\u003E\n  \u003Cul class=\"shareMethods\"\u003E\n    \u003Cli class=\"embed\"\u003E\n      \u003Clabel for=\"embed-code\"\u003EEmbed\u003C/label\u003E\n      \u003Cinput type='text' class=\"shareScreenEmbedCode\" value=\"code\" name=\"embed-code\" /\u003E\n    \u003C/li\u003E\n    \u003Cli class=\"url last\"\u003E\n      \u003Clabel for=\"embed-url\"\u003EURL\u003C/label\u003E\n      \u003Cinput type='text' class=\"shareScreenSSUrl\" value=\"code\" name=\"embed-url\" /\u003E\n    \u003C/li\u003E\n  \u003C/ul\u003E\n  \u003Cform class=\"emailShare\"\u003E\n    \u003Cfieldset\u003E\n      \u003Clegend\u003EEmail this\u003C/legend\u003E\n      \u003Cinput type=\"hidden\" class=\"shareDefaultMessage\" value=\"I think you will find this useful.\" /\u003E\n      \u003Cul\u003E\n        \u003Cli\u003E\n          \u003Clabel for=\"name\"\u003EYour name\u003C/label\u003E\n          \u003Cinput class='shareScreenFromName' type=\"text\" value=\"\" /\u003E\n        \u003C/li\u003E\n        \u003Cli\u003E\n          \u003Clabel for=\"mailID\"\u003EEmail to\u003C/label\u003E\n          \u003Cinput class=\"shareScreenMailID\" type=\"text\" value=\"\" /\u003E\n        \u003C/li\u003E\n        \u003Cli class=\"submit\"\u003E\n          \u003Clabel\u003E\u0026nbsp;\u003C/label\u003E\n          \u003Cinput class=\"shareSprite\" type=\"submit\" value=\"\" /\u003E\n        \u003C/li\u003E\n      \u003C/ul\u003E\n      \u003C/fieldset\u003E\n  \u003C/form\u003E\n\u003C/div\u003E\u003C!-- shareScreen ends here --\u003E\n","user_name":""},"html_eotfont_url_suffix":"-eot.js","slide_error_template":"\u003Cstyle type=\"text/css\"\u003E\n  .jsplayer-slide-error {\n    background-color: #000;\n    padding: 20% 0 13% !important;\n  }\n  .jsplayer-slide-error div {\n    text-align: center;\n  }\n  .jsplayer-slide-error img {\n    height: 79px !important;\n    margin: 0 0 10px;\n    width: 80px !important;\n  }\n  .jsplayer-slide-error .slide-error-body {\n    color: #eee;\n    font-family: 'Lucida Grande',Verdana, Arial, Helvetica, sans-serif;\n    padding: 0 !important;\n  }\n  .jsplayer-slide-error .slide-error-body p {\n    font-size: 0.8em;\n    line-height: 1.1em;\n    margin: 7px 0 11px;\n  }\n  .jsplayer-slide-error .slide-error-body input[type=button] {\n    margin: 7px 0 0;\n    padding: 7px 14px;\n  }\n\u003C/style\u003E\n\u003Cdiv class=\"jsplayer-slide-error\"\u003E\n  \u003Cdiv style=\"position:relative;\"\u003E\n    \u003Cimg src='//public.slidesharecdn.com/b/images/ssplayer/error_dudes-80x79.png' height=\"79\" width=\"80\" /\u003E\n    \u003Cdiv class=\"slide-error-body\"\u003E\n      \u003Cp\u003EWe were unable to load the slide.\u003C/p\u003E\n      \u003Cinput class=\"btn btn-large\" type=\"button\" value=\"Reload slide\" /\u003E\n    \u003C/div\u003E\n  \u003C/div\u003E\n\u003C/div\u003E\n","embed_code":"\u003Ciframe src=\"https://www.slideshare.net/slideshow/embed_code/key/A18dV3hfktsQNl\" width=\"670\" height=\"715\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" style=\"border:1px solid #CCC; border-width:1px; margin-bottom:5px; max-width: 100%;\" allowfullscreen\u003E \u003C/iframe\u003E \u003Cdiv style=\"margin-bottom:5px\"\u003E \u003Cstrong\u003E \u003Ca href=\"https://www.slideshare.net/harshadoddihal/hta-uncovered-february-2014-31757069\" title=\"HTA Uncovered february 2014\" target=\"_blank\"\u003EHTA Uncovered february 2014\u003C/a\u003E \u003C/strong\u003E from \u003Cstrong\u003E\u003Ca target=\"_blank\" href=\"http://www.slideshare.net/harshadoddihal\"\u003EDr.Harsha Doddihal\u003C/a\u003E\u003C/strong\u003E \u003C/div\u003E","embed_sizes":{"presets":{"preset4":{"displaySize":{"height":77,"width":70},"size":{"height":714,"width":668}},"preset1":{"displaySize":{"height":44,"width":40},"size":{"height":408,"width":382}},"preset2":{"displaySize":{"height":55,"width":50},"size":{"height":510,"width":477}},"preset3":{"displaySize":{"height":66,"width":60},"size":{"height":612,"width":572}}},"config":{"defaultPreset":"preset4"}},"meta_error_template":"\u003Cstyle type=\"text/css\"\u003E\n  .jsplayer-slide-error {\n    background-color: #000;\n    padding: 20% 0 13% !important;\n  }\n  .jsplayer-slide-error div {\n    text-align: center;\n  }\n  .jsplayer-slide-error img {\n    height: 79px !important;\n    margin: 0 0 10px;\n    width: 80px !important;\n  }\n  .jsplayer-slide-error .slide-error-body {\n    color: #eee;\n    font-family: 'Lucida Grande',Verdana, Arial, Helvetica, sans-serif;\n    padding: 0 !important;\n  }\n  .jsplayer-slide-error .slide-error-body p {\n    font-size: 0.8em;\n    line-height: 1.1em;\n    margin: 8px 0;\n  }\n  .jsplayer-slide-error .slide-error-body input[type=button] {\n    margin: 7px 0 0;\n    padding: 7px 14px;\n  }\n\u003C/style\u003E\n\u003Cdiv class=\"jsplayer-slide-error\"\u003E\n  \u003Cdiv style=\"position:relative;\"\u003E\n    \u003Cimg src='//public.slidesharecdn.com/b/images/ssplayer/error_dudes-80x79.png' height=\"79\" width=\"80\" /\u003E\n    \u003Cdiv class=\"slide-error-body\"\u003E\n      \u003Cp\u003EWe have encountered an error.\u003C/p\u003E\n      \u003Cp\u003EPlease refresh the page.\u003C/p\u003E\n    \u003C/div\u003E\n  \u003C/div\u003E\n\u003C/div\u003E\n","has_video":false,"autoplayOnEmbed":false,"fullscreen_bgcolor":"jsplBgColorBlack","page":1,"author_id":53349210,"next_slideshow_pos":null,"replayscreen":{"html":"\u003Ca href=\"#\" class=\"j-replay-button replay-button\" \u003E\n  \u003Ci class=\"fa fa-refresh\"\u003E\u003C/i\u003E\n  View again\n\u003C/a\u003E\n"},"slide_count":8,"image_bucket_location":"//image.slidesharecdn.com/htauncoveredfebruary2014-140228051012-phpapp02","wp_code":"[slideshare id=31757069\u0026doc=htauncoveredfebruary2014-140228051012-phpapp02\u0026type=d]","is_private":false,"mode":"html","slide_titles":[],"container":"svPlayerId","fullscreen_url":"/fullscreen/harshadoddihal/hta-uncovered-february-2014-31757069","twitter_share_text":"HTA Uncovered february 2014 by @Harshadod","track_slide_enable":1,"html_ttffont_url_suffix":".js","rel_slide_urls":[]},"slideshow_placeholder":"//public.slidesharecdn.com/b/images/thumbnail.png","downloads":{"allow":true,"sp_isdwnl":true},"asset_id":"98ac6f25d9ed7cf0629ed09dc3b07e08935c699e","li_bar":{"get_url":"/li_bar"},"default_tab":".svMoreAuthor","startSlide":1,"totalSlides":8,"fb_app_name":"slideshare","relative_static_origin_server":"//public.slidesharecdn.com/b/","top_nav":{"get_url":"/top_nav"},"activities":{"favorites":{"url":"/~/slideshow/favorites_list/31757069.json","total":1,"count":1}},"preview":"no","pvt":0,"userimage_placeholder":"//public.slidesharecdn.com/b/images/user-48x48.png","category":{"featured":0},"stats":{"url":"http://www.slideshare.net/~/slideshow/stats/31757069.json"},"bizo_partner_id":870,"flagging":{"flagged_value":null},"is_free_author":false,"version_no":"1393564255","gam_cat_name":"uncategorized","doc":"htauncoveredfebruary2014-140228051012-phpapp02","li_sponsored_content_related":{"placeholders":[{"id":"sponsored-content-1","position":0}],"url":"https://www.linkedin.com/csp/javascript"},"useHttp":1,"user":{"clips_number":0,"clipboards":null,"member_type":"non-member","clipboards_url":null},"show_branding":1,"dev":false});
  </script>

    <script src="http://public.slidesharecdn.com/b/ss_foundation/combined_player_document_init.js?0cdd696a33" type="text/javascript"></script>

    <script type="text/javascript">
      $(document).ready(function() {
        var $el = $('#svPlayerId');
        var classMap = {
          'document': 'document_player',
          'html': 'html_player',
          'infographic': 'infographic_player',
          'video': 'video_player'
        }

        player = new SSPlayer(slideshare_object.jsplayer);
        $(player).bind('slidechanged', function(e) {
          if (typeof(loadDataForSlide) === 'function') {
            loadDataForSlide(e.ssData.index);
          }
        });

        $el.addClass(classMap[player.config.player_type]);
      });
    </script>



  <script>

      slideshare_object.add_signin_link('.j-favorite');
      slideshare_object.add_login_source('.j-favorite', 'slideview.top_toolbar.like');
      slideshare_object.add_login_source('.j-save', 'slideview.top_toolbar.download');
      slideshare_object.addSigninFrom('.j-favorite', 'favorite');
      slideshare_object.bindToModalLogin('.j-favorite');
      slideshare_object.bindToModalLogin('.j-save');

    slideshare_object.bind_favorites('#slideview-container');

    $(document).ready(function() {

      // Favorites update

      // Remove some sidebar list items to limit the sidebar's height
      var mainContentHeight = $("#main-panel").height();
      var sidePanelItemHeight = $("#side-panel .j-related-item").first().outerHeight();
      var numItemToDisplay = Math.floor((mainContentHeight - 200) / sidePanelItemHeight);

      $("#side-panel .tabs-content .content").each(function() {
        $(this).find(".j-related-item").slice(numItemToDisplay - 2).remove();
      });

        var loadAdditionalFunctionality = function() {
          e = document.createElement('script');
          e.type = 'text/javascript';
          e.async = true;
          e.src =  '//public.slidesharecdn.com/b/ss_foundation/combined_slideview_loggedout.js?98ac6f25d9ed7cf0629ed09dc3b07e08935c699e';
          var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(e, s);
        };

        $(window).load(function() {
          loadAdditionalFunctionality();
        });


      // Load additionnal css
      $(window).load(function() {
        loadCSS("//public.slidesharecdn.com/b/ss_foundation/stylesheets/slideview.css?98ac6f25d9ed7cf0629ed09dc3b07e08935c699e");
      });
    });
  </script>

  

  <noscript>
    <img height="1" width="1" alt="" style="display:none;"
      src="//www.bizographics.com/collect/?pid=870&fmt=gif" alt="Bizographics tracking image" />
  </noscript>


  </body>
</html>
